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“πάντες ἄνθρωποι τοῦ εἰδέναι ὀρέγονται φύσει” 
 
“All men by nature desire knowledge” 
Aristotle, Metaphysics, 980 a 
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INTRODUCTION  
Obesity is a metabolic disorder considered as a risk factor for cardiovascular 
disease, one of the major cause of death worldwide. The upsurge in obesity fueled 
investigations in the effort to understand the pathophysiology of adipose tissues. 
Recently recognized as an organ, adipose tissue is divided in white (WAT) and 
brown fat (BAT). While WAT is mainly considered as energy storage site, BAT 
is involved in thermogenesis, by oxidizing fatty acids and dissipating energy as 
heat. The presence of thermogenic active adipocytes in WAT, resulting from a 
phenomenon called browning, has been recognized. The induction of browning 
confers protection against obesity and related disorders, paving the way for 
possible new therapeutic approaches. Moreover, the interaction between 
environmental cues and the organism has gained importance in the study of 
metabolic diseases. Epigenomic mechanisms of transcriptional regulation are 
viewed as an interface mediating the capacity of cells to adapt its own function to 
environment. Histone acetylation/deacetylation is one of the most intensely 
studied epigenomic modifications. Histone deacetylases (HDACs), by removing 
acetyl groups from histones, lead to transcriptional repression. HDACs have been 
involved in the regulation of metabolism in several organs.  
 
PRELIMINARY RESULTS & AIM 
We have previously demonstrated that class I HDAC inhibition reduced body 
weight and ameliorated glucose tolerance in murine models of obesity. HDAC3 
has been identified as main actor involved in these mechanisms. Therefore, we 
next investigated the role of HDAC3 in the physiology of adipose tissues.  
 
MATERIALS AND METHODS  
We used models of Hdac3 genetic inactivation, in vivo (adipose tissue specific 
Hdac3 knock out mouse) and in vitro (Hdac3 silencing in adipocyte cell line).  
 
RESULTS  
Adipose Hdac3 ablation induced a transcriptional switch leading to metabolic 
rewiring toward a futile cycle of fatty acid β-oxidation and de novo lipogenesis that 
sustained browning of WAT. Exposure to high fat diet (HFD) offset the effects 
of Hdac3 ablation, by interfering with lipid metabolism. We also observed 
remodelling of immune population resident in WAT in knock out vs. wild type 
mice. 
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CONCLUSIONS 
Based on our results, we propose HDAC3 as a regulator of the thermogenic 
response to cold in WAT, acting as a molecular brake of the metabolic rewiring 
that sustains WAT browning.  
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Globesity: prevalence, classification and aetiology 
	  
Obesity and overweight are defined as conditions where excessive accumulation of 
fat negatively affects health (Kopelman 2000). Fat accumulation, in turns, is 
caused by intake of excessive calories not counterbalanced by energy expenditure. 
The classic parameter that defines overweight and obesity is Body Mass Index 
(BMI), obtained with the following formula: weight (kg)/ height (m)2. BMI is 
used for weight classification, as following:  
• BMI between 18.5 and 24.9: healthy weight; 
• BMI ≥ 25: overweight; 
• BMI ≥ 30: obesity. 
However, BMI does not take into account different adiposity locations and ethnic 
differences. Therefore, other parameters are now currently used as, for example, 
waist circumference, waist to hip ratio, skinfold thickness and bioelectric 
impedance (Williams et al. 2015).  
Obesity and overweight are very common worldwide. Obesity is present in both 
industrialized and developing countries. WHO estimated that in 2016 39% of 
adults over 18 years (1.9 billion people) were overweight and 13% of these subjects 
were facing obesity (source: http://www.who.int/features/factfiles/obesity/en/). 
For these reasons, obesity is considered epidemic, defined by WHO with the term 
“globesity”. BMI distribution in a population is strictly correlated to socio-
economic conditions and industrialization. Improved economic condition is 
accompanied by a tendency to increased number of people affected by overweight 
or obesity. In the first phases of economic transition, obesity seems to be 
associated to the wealthier parts of the society. However, in later phases of 
economic transition increased prevalence of high BMI has also been observed in 
the poorest parts of the society (Kopelman 2000). The adoption of dietary habits 
and sedentary lifestyle similar to western and industrialized countries in 
developing countries, the so-called “westernization” of the diets, could explain this 
phenomenon.  
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Figure 1: from Kopelman et al. (Kopelman 2000).  
Obesity prevalence rates from 1960 to 2025.  
 
Obesity is considered as a major risk factor for cardiovascular disease, mainly 
stroke and heart disease. Moreover, it is associated to type II diabetes, insulin 
resistance, hypertension and hyperlipidaemia (Williams et al. 2015). Other 
conditions often associated to obesity are osteoarthritis, respiratory problems and 
increased prevalence of some cancers. In addition, overweighed and obese people 
are often discriminated; therefore this condition is often associated to 
psychological problems, such as depression, particularly in women (Haslam & 
James 2005).  
Increase of abdominal fat deposition, also known as visceral obesity, has a major 
role in determining the onset of insulin resistance, hypertension and 
hyperlipidaemia (Kopelman 2000). This is probably due to increased influx in 
portal circulation of fatty acids, cytokines and hormones, especially to the liver 
(Haslam & James 2005).  
Regarding factors that contribute to obesity, more than 50% of BMI variation on 
individuals could be explained by genetic contribution. However, polygenic 
susceptibility-environment interactions play a major role (Haslam & James 2005). 
In fact, monogenetic defects leading to obesity are very rare. This highlights the 
importance of environment as major contributor in the development of 
overweight and obesity. In particular, increased energy intake, promoted by 
intense industrial competition, seems to be the major determinant for the onset of 
obesity, accompanied by reduced physical activity (Haslam & James 2005).  
Obesity epidemic is nowadays one of the major medical challenge. The recent 
upsurge in obesity and related disorders prompted scientific community to find 
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and validate new therapeutic approaches to face this problem. However, 
contribution of stakeholders, community and health professionals should not be 
underestimated in developing new strategies to prevent and manage these diseases 
(Haslam & James 2005).   
	  
The adipose organ 
	  
The recent interest on pathophysiology of adipose tissues has been pushed by 
obesity epidemic. Adipose tissue has been recognized as an organ very recently. It 
has diverse functions: it helps to protect organs from mechanical hits, but also it 
has a role in regulation of hormonal reproductive axis. Most importantly, it is a 
central actor for regulation of systemic metabolism and energy homeostasis 
(Rosen & Spiegelman 2013). Classically, adipose tissue has been divided in two 
subtypes: brown and white adipose tissue. However, a third subtype has 
demonstrated to exist both in humans and rodents: beige fat.  
White adipose tissue  
	  
White adipose tissue (WAT) is located in subcutaneous and visceral regions. In 
mice, visceral fat is found in gonadal (epididymal in males), perirenal, mesenteric 
and epicardic areas. These depots correspond to omental area in humans. The 
distinction between these two subtypes is not only related to location but 
adipocytes may display distinct metabolic and functional features according to 
their subtype. This is probably due to cell-autonomous mechanisms, specific 
innervation and vascularization (Rosen & Spiegelman 2013). White adipocytes 
are typically characterized by the presence of unilocular lipid droplet that occupies 
almost entirely cellular volume. For this reason, white adipocytes have been seen 
merely as energy storage sites. 
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Figure 2: white adipocyte with unilocular lipid droplet. Nucleus is represented in blue, 
mitochondrion in green.  
 
Only recently this cell has been recognized as a central player in the regulation of 
energy homeostasis. Furthermore, WAT secretes a plethora of molecules, defined 
as adipokines, which regulate systemic metabolism through interaction with other 
metabolic organs. Adiponectin and leptin are the most famous adipokines 
regulating appetite behaviour and systemic metabolism. Leptin is secreted after a 
meal and, by regulating hypothalamic neuronal circuits, negatively affects appetite 
(Choe et al. 2016). Adiponectin, on the other hand, possesses anti-diabetic 
protective properties, ameliorates insulin resistance and stimulates lipid oxidation 
(Choe et al. 2016). Other secreted adipokines are resistin, TNFα (Tumor 
Necrosis Factor α) and also lipid molecules, such as palmitoleic acid (Rosen & 
Spiegelman 2013). White adipocytes evolved to store lipids during a good 
nutrition state and to release them during fasting to provide energetic molecules 
to energy-demanding tissues (Rosen & Spiegelman 2013). Energy storage is 
realized by the condensation of three free fatty acids (FFAs) to glycerol in 
triacylglycerols (TGs), which are stored in the lipid droplets. On the other hand, 
lipolysis is performed by three enzymes that subsequently catalyse the hydrolysis 
of FFAs from TGs: ATGL (Adipose Triglyceride Lipase) is the enzyme that 
catalyses the first hydrolysis, HSL (Lipe, hormone-sensitive lipase) is the 
diacylglycerol lipase and, finally, MGL (Monoglyceride Lipase) releases the last 
FFA from glycerol. FFAs are then released in the circulation and used by skeletal 
muscle or other tissues. De novo lipogenesis (DNL) also takes place in adipose 
tissue. Herman et al. (Herman et al. 2012) showed that DNL is regulated by 
glucose cellular flux in adipocytes via ChREBPβ. Increased glucose flux, mediated 
by Glut4 overexpression, enhanced expression of ChREBP, which, in turns, 
activates the expression of Fasn (Fatty Acid Synthase) and Acaca (Acetyl-CoA 
Carboxylase a), key enzymes for DNL. In particular, ChREBPβ isoform emerged 
as a novel regulator of DNL in adipose tissue in response to glucose. Of note, the 
authors also showed that high fat diet (HFD) reduced ChREBPβ expression in 
adipose tissue, thus reducing adipose DNL. In obese individuals both CHREBPα 
and CHREBPβ expression correlated with insulin sensitivity.  
During the adoption of diets enriched in fat, white adipose tissue responds to 
caloric overload by increasing cellular volume (hypertrophy) and, though to a 
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lesser extent, by increasing cell number (hyperplasia). Hypertrophy disrupts 
adipocyte function and metabolism via inflammatory and non-inflammatory 
mechanisms, thus worsening systemic metabolism and insulin sensitivity (Choe et 
al. 2016). On the contrary, induction of hyperplasia seems to exert beneficial 
property with respect to glucose systemic homeostasis and insulin sensitivity 
during obesity, probably because newly differentiated adipocytes may buffer and 
correctly store excess lipids from diet (Choe et al. 2016). In fact, it has been 
demonstrated that high fat diet (HFD) profoundly affects WAT metabolism 
(Cummins et al. 2014). In particular, HFD induces metabolic rewiring toward 
lipid storage preventing excessive lipid oxidation. Nutrient overload promotes 
accumulation of acyl-carnitines to buffer carbons from metabolic intermediates 
before incorporation in fatty acids and, thus, TGs. Moreover, the same authors 
demonstrated that HFD also reprograms glucose, amino acids and nucleotide 
metabolism. Finally, HFD reduces mitochondrial proteins and induces 
autophagy, possibly to limit lipid oxidation.  
Brown adipose tissue 
	  
Brown fat (BAT) is present in intrascapular and perirenal regions in mice. In 
humans, it is typically present in newborns. However, 18F-fluorodeoxyglucose 
positron-emission tomographic and computed tomographic (PET–CT) scans 
identified regions of active brown adipocytes in older humans, in particular in 
region from anterior neck to thorax (Cypess et al. 2009). Brown adipocytes are 
characterized by multilocular lipid droplets and higher mitochondria content. 
	  	  
 
	  
Figure 3: brown adipocyte with multilocular lipid droplets. Nucleus is represented in 
blue, mitochondria in green.  
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Brown fat participates in regulation of body temperature, by dissipating energy as 
heat. In particular, upon cold exposure, norephinefrine is released and activates 
thermogenesis in BAT primarily through β3-adrenergic receptors, which are 
abundantly expressed in this tissue. Brown adipocytes are characterized by the 
presence of the uncoupling protein 1 (UCP1), which dissipates the mitochondrial 
proton gradient, thus uncoupling ATP synthesis from respiratory chain (Rosen & 
Spiegelman 2013). Long chain free fatty acids (LCFAs) in BAT are required for 
UCP1 activity (Fedorenko et al. 2012). In fact, UCP1 acts as an LCFA-/H+ 
symporter with LCFA bound to the protein. Fatty acids are taken up from 
circulation via LPL (Lipoprotein Lipase) and translocated to cytoplasm by CD36 
(Cluster of Differentiation 36) (Calderon-Dominguez et al. 2015) or obtained by 
hydrolysis of TGs via lipolysis. Fatty acid β-oxidation is highly active in BAT, in 
fact deletion of genes important for this pathway (Cpt1b, carnitin-palmitoyl 
transferase 1b and Acsl1, acyl-CoA synthethase 1) demonstrated that β-oxidation is 
required for thermogenesis (Calderon-Dominguez et al. 2015). 
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Figure 4: from Hankir et al. (Hankir et al. 2018).  
Norephinefrine release by sympathetic nerves upon cold exposure activates β3-adrenergic 
receptors. This induces glucose internalization by GLUT1/4. Glycolysis generates 
dihydroxyacetone phosphate (DHAP), which is converted in glycerol-3-phosphate, 
pyruvate and lactate. Simultaneously, pentose phosphate pathway generates ribulose-5-
P and NADPH. Pyruvate and/or lactate are next transported in the mitochondria. 
Mitochondrial pyruvate is converted to acetyl-CoA by pyruvate dehydrogenase (PDH). 
Acetyl-CoA then enters in the TCA cycle as citrate, which is then exported to the cytosol. 
Citrate is converted back to acetyl-CoA by ATP-citrate lyase (ACLY), feeding DNL. 
Newly synthesized FAs are condensed in TGs. Upon cold exposure, TGs are rapidly 
hydrolyzed via ATGL, HSL and MGL. FFAs either activate UCP1 or enter in the 
mitochondria via ACSL1, CPT1, translocase and CPT2. Once inside the mitochondria, 
acyl-CoA is β-oxidized, generating proton gradient across the inner mitochondrial 
membrane as a result of oxidation of NADH and FADH2 generated during fatty acid 
oxidation. Glycerol is phosphorylated by glycerol kinase (GK) into glycerol-3-phosphate. 
Similarly, anaplerotic conversion of pyruvate to oxaloacetate is catalyzed by pyruvate 
carboxylase (PC). Oxaloacetate, in turns, is converted to malate, which is exported to the 
cytosol and converted back to oxaloacetate. Finally, phosphoenolpyruvate carboxykinase 
1 (PCK1) generates PEP from oxaloacetate, feeding glycerolneogenesis or used to obtain 
ATP via pyruvate kinase required for conjugation of FFAs with Coenzyme A. Fatty 
acids and glycerol released from lipolysis may enter an extracellular loop via fatty acid 
transport protein1 (FATP) and aquaporin 3/7/9 (AQP 3/7/9) as part of the fatty acid 
recycling pathway.  
 
Fatty acid β-oxidation, in fact, produces high amount of reducing equivalents 
NADH and FADH2 that feed electron transport chain and, thus, uncoupled 
respiration. However, glucose uptake is essential for thermogenesis, though to a 
lesser extent than lipids (Hankir et al. 2018). Glucose, in fact, has several roles in 
BAT: glucose-6-phosphate can supply pentose phosphate pathway producing 
NADPH, amino acids and nucleotides. Moreover, glucose provides glycerol for 
TG synthesis and glucose-derived pyruvate can be converted to lactate (Hankir et 
al. 2018). Finally, glucose is converted to pyruvate and, thus, to acetyl-CoA to 
feed TCA cycle. Importantly, glucose derived acetyl-CoA can be also converted to 
citrate by PDH (Pyruvate Dehydrogenase), which in turn exits the mitochondria 
and is converted back to cytosolic acetyl-CoA pool via ATP-citrate lyase (ACLY) 
to feed de novo fatty acid synthesis. At this regard, β3-adrenergic stimulation or 
cold exposure stimulate the concomitant expression of genes belonging to lipid 
oxidation and de novo lipogenesis in BAT (Yu et al. 2018; Mottillo et al. 2014), 
inguinal and gonadic WAT (Mottillo et al. 2014). The concurrent and 
paradoxical activation of these opposite pathways provides fuel for higher 
oxidative metabolism and supply substrates to high rate of lipid oxidation 
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(Mottillo et al. 2014). A recent paper from Weir et colleagues (Weir et al. 2018) 
used microdialysis to quantify BAT metabolism in human subjects. They showed 
that glucose uptake was increased in BAT during cold exposure. According to this 
study, glucose seemed to not be fully oxidized during cold-induced thermogenesis, 
as lactate production and release was high in BAT and accounts for more than 
half of glucose uptake in cold activated BAT. However, authors showed that 
lipolysis and subsequent fatty acid oxidation supplied the majority of energy 
demand related to BAT thermogenesis. Glutamate uptake was also increased in 
activated BAT, indicating that BAT also uses additional energy sources other 
than glucose and fatty acids. Of note, BAT metabolism was active also in warm 
conditions.  
Recently, it has been showed that BAT releases molecules with endocrine roles, 
collectively known as “batokines”, as for example FGF21 (Fibroblast Growth 
Factor 21), NRG4 (Neuregulin4) and BMP8b (Bone Morphogenetic Protein 8b) 
(Kajimura et al. 2017).  
Beige adipocytes and browning 
	  
A third type of adipocytes has been recognized very recently: beige adipocytes. 
These cells have been identified as UCP1+ cells within WAT depots. The 
appearance of beige adipocytes, a phenomenon defined as “browning”, has been 
originally found after cold exposure or β-adrenergic stimulation in mice (Rosen & 
Spiegelman 2013).  
 
	  
Figure 5: beige adipocyte. Nucleus is represented in blue, mitochondria in green.  
	  
Subcutaneous WAT (SubWAT) is more prone to undergo browning than visceral 
epididymal WAT (Kajimura et al. 2015). Importantly, beige adipocytes have been 
identified also in humans (Jespersen et al. 2013; Sparks et al. 2012; Shinoda et al. 
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2015). In addition to β-adrenergic stimulation and cold exposure, several inducers 
of browning and BAT activity have been identified, among which T3 
(triiodothyronine), natriuretic peptides (ANP and BNP), bile acids, irisin, 
FGF21. As opposed to BAT, where UCP1 expression and uncoupled respiration 
are high without stimulus, beige cells acquire thermogenic capacity upon proper 
stimulation (Sparks et al. 2012).  
Developmental origin of beige adipocytes is highly debated. It is clear that beige 
adipocytes do not share developmental program with classical brown adipocytes. 
Recent researches suggested that cold or β-adrenergic stimulation induce de novo 
beige adipocyte differentiation and activation of Ucp1 expression in mature 
adipocytes, which likely derive from beige lineage (Kajimura et al. 2015).  
The study from Shabalina et al. (Shabalina et al. 2013) showed that mitochondria 
from beige fat were functionally capable to perform UCP1-dependent 
thermogenesis. Of note, oxidative phosphorylation capacity was lower in BAT or 
beige mitochondria compared to heart mitochondria. In this study, however, 
BAT thermogenic capacity was still higher than that of beige fat. Proteomics 
analysis of beige fat mitochondria versus BAT mitochondria identified the 
arginine-dependent creatine metabolism as a peculiar characteristic of cold-
activated beige adipocytes (Kazak et al. 2015). Importantly, the authors 
demonstrated the occurrence of a creatine-driven futile cycle, which increased 
ADP-dependent respiration and thermogenesis. In fact, futile cycle of 
phosphocreatine hydrolysis and creatine phosphorylation by CK (Creatine 
Kinase) increased ADP concentration in mitochondria, thus ADP-dependent 
electron transport chain. Accordingly, reduced creatine metabolism in vivo 
diminished oxidative metabolism in thermogenic tissues BAT and beige fat. 
 
	  
Figure 6: from Kazak et al. (Kazak et al. 2015).  
Models of creatine futile cycle: a) model based on phosphocreatine direct hydrolysis; b) 
model based on multiple phosphotransfer events.  
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Moreover, inhibition of creatine metabolism reduced thermogenic capacity of 
Ucp1-/- mice, thus indicating that creatine metabolism role in thermogenesis is 
UCP1-independent. These results are indicative of metabolic pathways 
influencing thermogenesis in beige adipocytes and BAT that do not need UCP1 
uncoupling activity. Furthermore, another study demonstrated that induction of 
browning by Prdm16 (Pr domain containing 16) overexpression (Prdm16 Tg mice) 
was sufficient to increase thermogenic response in inguinal WAT, even in absence 
of Ucp1 (Prdm16 Tg x Ucp1-/- mice), further suggesting the existence of 
thermogenic mechanisms alternative to UCP1 activation (Ikeda et al. 2018). In 
particular, these authors found a role of SERCA2b (Atp2a2, ATPase Ca2+ 
transporting slow twitch 2)-RyR2 (Ryanodine Receptor 2) pathway in mediating 
UCP1-independent thermogenesis in beige adipocytes. Prdm16 Tg x Ucp1-/- mice 
and Prdm16 Tg mice displayed resistance to HFD-induced obesity and glucose 
intolerance, indicating that induction of beige adipocytes protected against obesity 
and related metabolic dysfunction without requirement of UCP1 activation. 
Interestingly, Prdm16 Tg x Ucp1-/- mice displayed increased respiratory exchange 
ratio (RER) than Ucp1-/- mice, indicating that Prdm16 Tg x Ucp1-/- mice 
preferentially utilized carbohydrates as energy source or, in other terms, beige 
adipocytes switched from fatty acid to glucose metabolism in absence of UCP1. 
To explain their results, the authors proposed the following model: 
norephinefrine, by interacting with α1 and β3-adrenergic receptors, increases Ca2+ 
flux in the cytoplasm, which is subsequently recycled in endoplasmic reticulum by 
SERCA2b, consuming ATP. Ca2+ is likely transported to the mitochondria where 
it activates PDH phosphatase 1c (PDP1c) and oxidation of glucose-derived 
pyruvate in TCA cycle and following ATP synthesis. Thermogenesis is achieved 
when uncoupling of ATP hydrolysis by SERCA2b and Ca2+ transport is 
occurring. This pathway seems to be operative in beige adipocytes, which display 
higher ATP synthase than BAT.  
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Figure 7: adapted from Ikeda et al. (Ikeda et al. 2018). 
Model of UCP1-independent thermogenesis via uncoupling of Ca2+ transport and ATP 
hydrolysis by SERCA2b.  
	  
Several studies have clearly demonstrated that induction of beige adipocytes 
and/or activation of BAT by treatment with pharmacological agents or genetic 
modifications protect against diet-induced obesity and prevent dysfunction of 
systemic metabolism (Kajimura et al. 2015). Min et al. (Min et al. 2016) obtained 
human adipogenic progenitors that resembled many features of beige phenotype. 
When implanted in HFD-fed NOD-scid IL2rgnull mice, human derived adipocytes 
maintained enhanced systemic glucose tolerance. Of note, these cells displayed 
increased expression of IL33 (Interleukin 33) and PCSK1 (Proprotein-Convertase 
Subtisilin/Kexin type 1) and its substrate PENK (Proenkephalin), thus suggesting 
that neuroendocrine secreted factors could contribute to amelioration of glucose 
metabolism related to human beige adipocytes implantation.  
Immune cells are adipocytes partners that contribute in the regulation 
of adipose tissue pathophysiology  
	  
Adipose tissues are not only composed by adipocytes but other cell types reside 
within it: endothelial cells, fibroblasts, preadipocytes, stem cells and immune cells. 
Actually, mature adipocytes only constitute 20-40% of the entire tissue (Rosen & 
Spiegelman 2013).  The role of immune cells in adipose tissue pathophysiology 
raised interest of scientific community because their pro-inflammatory functions 
exerted as consequence of HFD provide a link between obesity and dysregulation 
of systemic metabolism. However, immune cells in adipose tissue do not play only 
a pro-inflammatory role in obesity but also secrete anti-inflammatory cytokines 
that participate in regulation of tissue function.  
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Innate immune cells in WAT pathophysiology  
 
Hypertrophic adipocytes have been linked to altered adipose tissue functionality. 
In fact, hypertrophy has been associated to increased expression and release of 
inflammatory cytokines, increased hypoxia and lipolysis with related increase in 
release of FFAs that are ectopically accumulated in other organs and tissues, such 
as liver and skeletal muscle, thus worsening systemic metabolism (Choe et al. 
2016).  
 
 
Figure 8: from Choe et al. (Choe et al. 2016). 
Characteristics of hyperplastic versus hypertrophic adipocytes in obesity.  
 
It has been demonstrated that, in obesity, hypertrophy drives necrotic-like 
adipocytes death. This, in turns, promotes accumulation of macrophages in WAT 
that surround dead cells in “crown-like structures” (CLSs) (Cinti et al. 2005). 
Crown-like structures are prevalent in visceral fat (ViscWAT), suggesting that 
visceral adipocytes are more prone to hypertrophy driven-death. Adipocytes size 
seems to be a critical factor to trigger death in ViscWAT, whereas it seems to be 
more tolerated by subcutaneous adipocytes. This peculiar characteristic associates 
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increased ViscWAT with increased incidence of metabolic disorders (Murano et 
al. 2008). Macrophages appearance has been linked with insulin resistance (Xu et 
al. 2003). This is related to increased release of pro-inflammatory cytokines. 
Actually, adipose tissue resident macrophages (ATMs) are divided in two 
subtypes: M1 or “classically activated” and M2 “alternatively-activated” 
macrophages. M1 macrophages typically express surface markers CD11c (Itgax, 
integrin alpha X) together with classical macrophages markers F4/80 (Adgre1, 
adhesion G-protein coupled receptor E1) and Cd11b (Itgam, integrin alpha M) (Huh 
et al. 2014). Polarization towards M1 macrophages is induced by factors as 
lipopolysaccharide (LPS) and interferon γ (IFNγ) and, in turns, M1 macrophages 
release pro-inflammatory molecules, such as tumor necrosis factor α (TNFα), 
interleukins 6 (IL6), 12 (IL12) and 1β (IL1β) and NO (nitric oxide) (Mathis 
2013; Huh et al. 2014). In fact, Il6 and Nos2 (Nitric Oxide Synthase 2, inducible) 
are considered gene markers of M1 subtype, together with Ccl2 (Chemokine C-C 
Motif Ligand 2). On the other hand, M2 macrophages are present in lean 
subjects and are characterized by the expression of surface markers CD206 (Mrc1, 
mannose receptor, C type 1), CD301 (CLEC10A, C-type lectin domain containing 
10A) and Arg1 (Arginase 1). Conversely, M2 subtype releases anti-inflammatory 
cytokines, for example IL10 and IL1Ra (Interleukin 1 Receptor Antagonist) 
(Huh et al. 2014). However, a recent study identified different subtypes of 
macrophages that do not endow classical M1 or M2 phenotype. Hill et al. (Hill et 
al. 2018) showed the presence of CD9+ ATMs, especially in CLSs. The CD9+ 
macrophages presented lysosomal-like particles loaded with high amount of 
intracellular lipids. Transfer of CD9+ macrophages to lean recipient donor caused 
a shift of gene expression toward a profile more similar to that of obese adipose 
tissue, indicating CD9+ macrophages as primary actors in inflammation related to 
obesity. On the other hand, the authors also demonstrated the presence of 
another macrophage population, Ly6C+, with no lipid particles and interspersed 
in the adipose tissue. These macrophages expressed genes related to angiogenesis 
and tissue organization; in fact their transfer to a lean recipient mouse was 
accompanied by increased expression of genes belonging to adipose tissue 
physiology. Importantly, the authors also showed CD9+ ATM with lipid-laden 
structures associated to CLSs in human visceral fat of obese subjects. 
Furthermore, they showed a correlation between BMI and CD9+ ATMs, further 
indicating that the presence CD9+ ATMs is linked to obesity also in humans.  
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The presence of other immune cell types has been linked to obesity related 
metabolic dysfunctions. Talukdar et al. (Talukdar et al. 2013) showed the 
presence of neutrophils (Ly6G+) in WAT (ATNs, adipose tissue neutrophils) 
after 3 days of HFD exposure which remained constant up to day 90 of exposure. 
Expression of neutrophil elastase Ne was higher in HFD fed mice and Ne genetic 
or pharmacologic inhibition reduced ATNs and improved hepatic and adipose 
tissue insulin sensitivity. Moreover, Ne knock out mice displayed increased 
expression profile of M2 macrophages in adipose tissue and, conversely, reduced 
expression of M1 subset genes, indicating that Ne may have a role in recruiting 
M1 macrophages. Moreover, also mast cells have been implicated in obesity-
inflammation (Mathis 2013). 
Eosinophils in the adipose tissue secrete cytokines such as IL4 and IL13 that 
polarize macrophages toward M2 subset (Huh et al. 2014). Davina et al. (Davina 
et al. 2011) demonstrated that 90% of IL4 competent cells in visceral WAT of 
chow diet fed mice were eosinophils. Moreover, HFD fed mice displayed reduced 
levels of eosinophils. The same authors elegantly demonstrated that eosinophils 
and Il4 and Il13 sustained the presence of alternatively activated macrophages in 
visceral WAT. Eosinophil-deficient mice displayed increased body fat and 
impaired glucose tolerance, suggesting that eosinophils play an anti-inflammatory 
role in obesity.  
Finally, also recently discovered innate lymphoid cells (ILCs) and related release 
of IL5 and IL13 have been implicated in maintaining adipose homeostasis under 
normal conditions (Mathis 2013).  
Adaptive immunity plays a role in adipose tissue pathophysiology  
 
In addition to innate immune cells, also adaptive immunity has been implicated in 
adipose tissue pathophysiology. At this regard, Nishimura et al. (Nishimura et al. 
2009) showed increased number of CD8+ T lymphocytes within CLSs in adipose 
tissue of obese mice. In parallel, CD4+ T lymphocytes were not associated to 
CLSs and their number was decreased in visceral WAT of obese mice. Moreover, 
CD8+ T lymphocytes infiltration was detected within 2 weeks of HFD exposure, 
even before macrophages infiltration. Accordingly, treatment with α-CD8 
antibody reduced M1 macrophages, number of CLSs and expression of Tnfα and 
Il6 in HFD fed mice. CD8 block with specific antibody also ameliorated glucose 
tolerance. By performing in vitro co-culture experiments, the same authors 
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demonstrated that obese visceral WAT induced T cell proliferation. Additionally, 
interaction between visceral epididymal adipose tissue and CD8+ T lymphocytes 
was essential to induce monocyte differentiation to macrophages, macrophages 
migration and activation, measured as Tnfα expression.  
B cells have been also found in visceral WAT of HFD fed mice within 4 weeks of 
diet exposure (Winer et al. 2011), together with IgG and IgM associated to 
CLSs. HFD fed Bnull mice, a model with genetic B cells deprivation, showed 
improved glucose tolerance and insulin sensitivity with reduced number of M1 
macrophages and CD8+ T cells. In fact, the same authors demonstrated that T 
lymphocytes were required for B cells-driven metabolic impairments during HFD 
and that, in turn, B cells modulated CD8+ T lymphocytes, via MHC II (major 
histocompatibility complex II), and CD4+ T lymphocytes, via MHC I. Moreover, 
IgG produced by B cells in ViscWAT also participated in worsening glucose 
homeostasis and insulin sensitivity. Importantly, insulin-resistant obese human 
subjects displayed a peculiar serum IgG panel different from that of insulin-
sensitive obese human subjects, highlighting the importance of B cell function 
and activity in human pathology.  
Winer et al. (Winer et al. 2009) also characterized CD4+ T lymphocytes and 
related sublineages in obese mice and human subjects. HFD fed mice and obese 
subjects displayed increased T helper1 (Th1) subset and reduced level of CD4+ 
Foxp3+ T cells (Treg, T regulatory), with increased Th1:Treg ratio. This peculiar 
T cells subset was, at least in part, determined by antigen-driven mechanisms. 
CD4+ T lymphocytes transfer in HFD fed RAGnull mice, which lacked 
lymphocytes, caused reduced weight gain, reduced levels of obesity-related 
adipokines leptin, resistin and Mcp1 (Ccl2, chemokine (C-C motif) ligand 2) and 
ameliorated glucose tolerance. Interestingly, immunotherapy increasing CD4+ 
Foxp3+ T cells improved glucose tolerance during HFD exposure and increased 
also Il10-secreting M2 macrophages in ViscWAT. The authors proposed that 
Th2 and Treg gradually fail to modulate Th1 expansion in obesity, leading to the 
onset of pro-inflammatory environment in WAT that worsens systemic glucose 
tolerance.  
With respect to CD4+ Foxp3+ cells, Feuerer et al. (Feuerer et al. 2009) 
demonstrated that these cells represent half of CD4+ T cells in ViscWAT of lean 
mice with lower number in subcutaneous WAT. The abdominal WAT CD4+ 
Foxp3+ cells displayed 136-fold increase in Il10 expression compared to 
lymphnodes Treg. By analyzing T cell receptor (TCR) repertoire the authors 
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found that fat Treg endowed TCR repertoire different from that of fat T 
conventional cells (Tconv), indicating that Treg population in ViscWAT is not 
derived from local conversion of Tconv cells. The author also raised the possibility 
that the TCR-driven high frequency of Treg in adipose tissue may be related to 
the local recognition of specific antigen. Importantly, Treg resulted to have a role 
in regulating glucose homeostasis in obesity. In vitro assays demonstrated that 
Treg-specific cytokine IL10 reduced the TNFα-mediated insulin resistance in 
3T3-L1 adipocytes by cell-autonomous mechanisms, thereby showing the 
importance of Treg in regulating adipose tissue homeostasis and systemic 
metabolism.  
Finally, natural T killer cells (NTK) have been somewhat implicated in 
inflammation related obesity but their exact role remains to be further elucidated 
(Mathis 2013).  
Thus, it appears that innate and adaptive immunity cooperate both in normal 
adipose tissue physiology and in metabolic disorders. In fact, anti-inflammatory 
cells (mainly M2 macrophages and Treg cells) act as brake of inflammatory 
response in early stages of obesity. However, excess energy and adipocyte 
dysfunction lead to unbalanced equilibrium between anti- and pro- inflammatory 
immune cells that, in turn, induce dysregulation in the immune response and 
metabolic systemic dysfunction. However, immune cells unbalancing in adipose 
tissue during obesity is a dynamic and reversible phenomenon (Choe et al. 2016).   
Immune cells have been implicated in inflammation and obesity not only in 
ViscWAT but also in BAT, though they are present in a lesser extent (Brown et 
al. 2018). Inflammatory mechanisms in obesity seem to impair thermogenic 
response in BAT and beige adipocytes recruitment.  
Immune cells are not only implicated in inflammation and obesity. For example, 
during fasting and weight loss macrophages are recruited to fat to buffer excessive 
free fatty acids (Rosen & Spiegelman 2013). Moreover, it has been suggested that 
ATMs modulate extracellular matrix thus playing a role in adipose tissue 
remodeling and angiogenesis, also during adipogenesis (Choe et al. 2016). 
Importantly, both innate and adaptive immune cells play a role in thermogenesis 
and browning (Brown et al. 2018). In particular, M2 macrophages, eosinophils, 
ILC2 cells, Treg and iNTK cells have been implicated in regulation of BAT 
activation and/or WAT browning. Several mechanisms of macrophages 
involvement in BAT- and beige-related thermogenesis have been proposed: their 
role in producing norephinefrine is still debated. However, these cells have been 
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involved in clearance and degradation of this neurotransmitter, thus reducing 
response to cold and thermogenesis. Finally, a role in innervation has also been 
showed (Brown et al. 2018). 
 
 
Figure 9: from Mathis (Mathis 2013). 
Immune cells in the pathophysiology of adipose tissue. 
Epigenetics  
 
The term “epigenetics” refers to heritable changes in gene expression that do not 
imply changes in DNA sequences. Epigenetic mechanisms comprise chromatin 
modification, DNA cytosine modifications (methylation and hydroxymethylation) 
and non-coding RNAs-driven silencing. Epigenetic regulation of gene expression 
is viewed as a way to sense the external environment and modulate genome 
function. Therefore, modulation of chromatin organization is one of the 
mechanisms by which cells can modulate their functions in response to changing 
environmental conditions. In fact, chromatin can be viewed as an “interface” 
between environment and nuclear function throughout lifespan (Benayoun et al. 
2015). Regulation of chromatin organization is exerted by chemical modifications 
on DNA cytosine or histone aminoacidic residues. The role of these modifications 
is to regulate DNA accessibility to transcriptional factors and coregulators and/or 
proximity of regulatory elements to gene sequences. To simplify the complexity of 
chromatin 3D organization, the state of opened chromatin is defined as 
“euchromatin”, whereas the state of lower DNA accessibility is defined as 
“heterochromatin”. However, chromatin condensation in a particular locus is a 
much more dynamic phenomenon and the final result in terms of gene expression 
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is actually due to the contribution of different epigenomic marks in the same 
locus. In fact, chromatin modifications constitute the epigenomic code, as already 
hypothesized since 2000 (Strahl & Allis 2000). Amino acid residues in histone 
tails can be modified via phosphorylation, methylation, acetylation, ADP-
rybosilation, SUMO-ylation, biotinylation and ubiquitinylation. Epigenomic 
enzymes that are responsible of adding a particular chemical modification to 
histone or DNA are classically defined as “writers”. Enzymes defined as “erasers” 
catalyze the opposite reaction. Finally “readers” are the enzymes that actuate the 
final epigenetic response. To mention some elements of the histone code, active 
promoters are usually marked by histone 3 lysine 4 trimethylated (H3K4me3); 
active enhancers by histone 3 lysine 4 mono and dimethylated (H3K4me1/me2) 
and histone 3 lysine 27 acetylated (H3K27ac); genes actively transcribed by 
histone 3 lysine 36 or 79 trimethylated (H3K36me3, H3K79me3). Whereas, 
silenced chromatin is associated to histone marks such as histone 3 lysine 9 
trimethylated (H3K9me3), histone 3 lysine 27 di- and trimethylated 
(H3K27me2/me3), histone 4 lysine 27 di- and trimethylated (H4K27me2/me3) 
and histone 4 lysine 20 trimethylated (H4K20me3) (Longo et al. 2017). 
 
 
Figure 10: adapted from Longo et al.(Longo et al. 2017). 
Chromatin spatial organization regulates gene expression. Gene expression patterns 
result from combination of different epigenomic marks.   
 
Recently, the idea that metabolic status of the cells is integrated in epigenetic 
regulation of genome has emerged (Lu & Thompson 2012). At this regard, 
epigenomic enzymes use as cofactors or substrates molecules that are part of 
intermediate metabolism. This observation suggests a tight link between 
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metabolism and epigenomic regulation. Thus, metabolite levels in a particular 
metabolic state can influence epigenomic enzymes activity, thereby regulating 
gene expression (Ferrari et al. 2018).  
Acetylation of histone tails is catalyzed by a class of enzymes called histone 
acetyltransferases (HATs) and acetyl-CoA is used as substrate for histone 
acetylation. At this regard, Wellen et al. (Wellen et al. 2009) demonstrated that 
ATP-citrate lyase (ACLY) is fundamental to provide acetyl moieties to HATs in 
the nucleus. In fact, these authors showed that ACLY is present not only in the 
cytoplasm but also in the nucleus. Cytoplasmic citrate enters in the nucleus and is 
used by ACLY, obtaining nuclear acetyl-CoA, which, in turn, is used by HATs. 
Moreover, they also showed that glucose is the principal source to sustain histone 
acetylation. However, fatty acids and, in certain conditions, acetate, can be also 
used as source of acetyl-CoA for histone acetylation (McDonnell et al. 2016; Gao 
et al. 2016). On the other hand, histone deacetylases (HDACs) are erasers of 
histone acetylation. Shimazu et al. (Shimazu et al. 2012) demonstrated that 
ketone body β-hydroxybutyrate inhibits endogenously class I HDACs. Class III 
HDACs, also known as sirtuins, activity is regulated by NAD+/NADH ratio, thus 
these epigenomic enzymes are defined as “sensors of energy status” of the cell.   
Methylation of DNA or of lysine or arginine residues on histone tails is the result 
of equilibrium between methylation and demethylation activity. Methylator 
enzymes are DNA methyltransferases (DNMT) and histone methyltransferases 
(HMT) which use S-adenosylmethionine (SAMe) for transferring methyl groups 
to the proper substrate, forming S-adenosylhomocisteine (SAH) as by-product. 
Both SAMe and SAH are intermediate metabolites of the so-called “one-carbon 
metabolism”. Methionine, folate, choline and vitamins B12 and B6 also influence 
this pathway and, in turn, epigenetic methylation. Histone demethylation may 
occur thanks to the activity of LSDs (Lysine-Specific Demethylases), which use 
FAD as cofactor, or JHDMs (Jumonji-C domain containing Histone 
Demethylases), which use for their enzymatic reaction O2, Fe(II) and α-
ketoglutarate, which is converted to succinate. Whereas, DNA methylation is 
probably exerted by two step reactions: the first conversion of 5-methylcytosine 
(5-mC) in 5-hydroxymethylcytosine (5-hmC) is catalysed by TETs (Ten-Eleven 
Translocation), which share catalytic mechanisms with JHDMs. In addition, 
fumarate and succinate exert by-product negative inhibition to TETs and 
JHDMs, competing with α-ketoglutarate.  
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Overall, both methylation/demethylation and acetylation/deacetylation activities 
are modulated by molecules that play central roles in cellular metabolism.  
 
 
Figure 11: from Ferrari et al. (Ferrari et al. 2018). 
Metabolic intermediates are substrates of chromatin modifying enzymes.  
Obesity and epigenetics  
 
Obesity and related metabolic complications are multi-faceted disorders and 
environment plays an important role in their onset. From this perspective, a link 
between obesity and epigenomic-based pathological mechanisms has been 
hypothesized. Several investigations are focusing on how nutritional effects during 
gestation are maintained in the following generation, as epigenetic memory of a 
former metabolic state. This phenomenon is also known as “transgenerational 
epigenetic inheritance” (Longo et al. 2017). At this regard, one of the most 
famous evidences is the “Dutch Hunger Winter famine” case study, that refers to 
the famine occurring in Netherlands from November, 1944 to May, 1945 (Lumey 
et al. 2007). By studying offspring of mothers exposed to famine, the association 
between exposure to famine during gestational period and higher body mass 
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indexes of female offspring at the age of 59 years has been established (Stein et al. 
2007). In a follow-up study, females exposed to famine during early gestational 
period, i.e. periconceptional period, showed hypomethylation at IGF2 (Insulin 
Growth Factor 2) differentially-methylated regions, a gene important for growth, 
after nearly 60 years from the event. This study was the first to highlight that 
environmental conditions during human gestation are associated to epigenetic 
changes that are maintained later in life. Recently, epigenome-wide association 
studies (EWAS) lead to the identification of several epigenomic traits linked to 
obesity and metabolic disorders. For example, EWAS conducted in African 
American adult population identified numerous methylation variants associated 
with BMI and waist circumference (WC) (Demerath et al. 2015). The authors 
observed that over 100 biological pathways were enriched for methylation pattern 
associated to BMI and WC. In particular, they found pathways related to lipid 
and energy metabolism, immune function, adipocyte, neuronal and chondrocyte 
differentiation and development. To mention some of the genes, CPT1A 
(Carnitine Palmitoyl Transferase 1A, implicated in fatty acid β-oxidation), 
ABCG1 (ATP-Binding Cassette subfamily G member 1, implicated in 
macrophage cholesterol and phospholipid transport and lipid homeostasis) and 
HIF3A (Hypoxia Inducible Factor 3 subunit alpha) methylation loci were 
previously suggested to be associated to obesity. In fact, another study identified 
DNA methylation on HIF3A locus associated with BMI in adult population with 
European origin (Dick et al. 2014). This association was recorded both in whole 
blood DNA and in adipose tissue sample. Moreover, the authors suggested that 
increased BMI possibly caused increased HIF3A methylation.   
Overall, the main challenges of this field of investigation are to validate epigenetic 
marks in blood circulating cells as early markers of the onset of metabolic diseases 
and to find environmental cues that alter gene expression and, ultimately, 
metabolism in order to envision new possible therapeutic strategies (Ferrari et al. 
2018).  
Histone deacetylases 
 
One of the most intensely studied histone modifications is 
acetylation/deacetylation. Acetylation of ε-amino group of histone lysines, by 
neutralizing the positive charge, relaxes chromatin structure and increases the 
accessibility of transcription factors and coregulators to DNA consensus 
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sequences. Acetylated histone marks are binding sites for bromodomain proteins 
(readers), which often activate transcription (Haberland et al. 2009). The opposite 
reaction is catalysed by epigenomic modifiers histone deacetylases (HDACs). The 
removal of acetyl groups compacts chromatin, thereby repressing transcription. 
HDAC family comprises 18 proteins with highly conserved deacetylase domain, 
divided in four subclasses (Haberland et al. 2009).  
 
 
Figure 12: from Haberland et al. (Haberland et al. 2009). 
Class I, class IIa and IIb and class IV histone deacetylases features.   
 
Members of class I HDACs are HDAC1, HDAC2, HDAC3 and HDAC8. 
They are ubiquitarian and have nuclear localization.  
Class II HDACs are further divided in IIa and IIb subclasses. Class IIa comprises 
HDAC4, 5, 7 and 9. Class IIa HDACs are cytoplasmic and, once 
phosphorylated, they shuttle in the nucleus where they act as adaptors for 
recruiting other coregulators for formation of protein complexes. Class IIb 
comprises HDAC6 and 10. HDAC6 exerts its activity on cytoplasmic proteins, 
such as tubulin and other cytoskeleton proteins, whereas HDAC10 function is 
not known.  
Class III HDACs are also known as sirtuins and their activity is dependent on 
NAD+/NADH ratio. Therefore, cell energetic state modulates sirtuins activity.  
Finally, HDAC11 is the only protein constituting class IV HDACs and its 
activity is poorly understood.  
Overall, HDACs function is highly specific for each isoform, as murine models 
with specific ablation of Hdac isoforms have shown (Haberland et al. 2009). 
Several studies showed the role of HDACs in the regulation of metabolism 
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(Ferrari et al. 2012). Our laboratory has previously demonstrated that HDAC7, 3 
and 1, together with corepressors NCOR1/2 (Ncor1, nuclear receptor corepressor 
1, and Ncor2/Smrt, silencing mediator of retinoic and thyroid receptors), regulated 
the expression of Cyp7a1, encoding for the protein that catalyzes the key-limiting 
step of bile acid synthesis from cholesterol in the liver (Mitro et al. 2007). In 
particular, HDAC7 played a pivotal role in these mechanisms. Mihaylova et al. 
(Mihaylova et al. 2011) showed that class II HDACs shuttle in the nucleus in 
response to glucagon in the liver. In the nucleus they mediate the induction of 
gluconeogenetic genes through, at least in part, deacetylation and activation of 
FOXO (Forkhead box) transcription factors. Furthermore, shRNA-mediated 
silencing of these HDACs reduced blood glucose levels in several models of 
obesity. Several studies demonstrated the involvement of HDACs in the 
regulation of metabolic gene program in skeletal muscle (Ferrari et al. 2012).  
HDAC3 is a regulator of metabolism in several organs  
  
HDAC3 is a member of class I HDACs. HDAC3 forms protein complexes with 
NCOR1 or NCOR2/SMRT (Sun et al. 2013). Watson et al. (Watson et al. 
2012) showed the structure of HDAC3/SMRT-DAD (DAD: deacetylase 
activation domain) complex. HDAC3 protein structure is formed by eight-
stranded parallel β-sheets surrounded by α-helices. A tyrosine adjacent to the 
active site tunnel is present only in this HDAC isoform, possibly providing 
substrate specificity. The SMRT-DAD interacts with HDAC3 N-terminal 
region. Moreover, the authors observed the presence of D-myo-inositol-1, 4,5,6- 
tetrakisphosphate (Ins(1,4,5,6)P4 or IP4) tightly bound in a highly basic pocket at 
the interface of HDAC3 and DAD. IP4 appeared to be required for the formation 
of the complex, acting as “intermolecular glue” between two proteins. In fact, 
Both IP4 and SMRT-DAD were required for HDAC3 enzymatic activity. Of 
note, IP4 binding is general requirement for class I HDACs, with the exception of 
HDAC8. In addition, another group showed that Tyr298 was important for 
HDAC3 activity in the presence of SMART-DAD (Sun et al. 2013). However, 
by genetic Hdac3 manipulation the authors showed that the deacetylase activity 
was dispensable for HDAC3-mediated gene repression. Rather, formation of 
NCOR/SMRT-HDAC3 complex was absolutely indispensable for HDAC3 
genomic recruitment and transcriptional repression in the liver.  
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Figure 13: adapted from Watson et al. (Watson et al. 2012). 
Interaction between SMRT-DAD (green), HDAC3 (grey) and IP4 (dark red).  
 
Several studies showed a clear role of HDAC3 in regulating lipid metabolism in 
different organs and tissues.  
Hepatic Hdac3 deletion caused de-repression of genes important for lipid and 
steroid metabolism, thus inducing increased lipid accumulation in the liver 
(Knutson et al. 2008). These effects were due to Pparg upregulation and 
consequent activation of PPARγ gene networks. A study from another group 
using a different liver-specific knock out mouse proposed a model whereby 
HDAC3 in the liver regulates metabolism in circadian fashion (Feng et al. 2012). 
In particular, these authors observed that HDAC3 was recruited to over 14.000 
sites in the liver during the diurnal period (non-active phase in mice). However, 
HDAC3 recruitment dropped during the dark phase (active period in mice). 
Moreover, they observed decreased H3K9ac in the same sites and decreased RNA 
polymerase II recruitment at TSS of genes downstream HDAC3 binding within 
10 kb, indicating that they were actively repressed. HDAC3 recruitment during 
light period overlapped with that of NCOR and REV-ERBα, a nuclear receptor 
key regulator of the circadian clock, indicating that REV-ERBα recruits 
HDAC3-NCOR complex in an oscillatory circadian mode. Liver-specific Hdac3 
knock out increased hepatic fat content, accompanied by increased de novo fatty 
acid synthesis. In a following study, the same group of research (Sun et al. 2012) 
proposed a model whereby during non-active and fasting period HDAC3 is 
recruited to the genome and represses the expression of genes involved in lipid 
synthesis and sequestration, thereby routing metabolic intermediates to 
gluconeogenesis. During the active and feeding period HDAC3 is not recruited to 
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the genome, leading to de-repression of lipogenic genes, thus inducing storage of 
energy in the form of lipids. Intriguingly, hepatic Hdac3 knock out model 
displayed severe hepatosteatosis but insulin sensitivity was not impaired. In fact, 
expression of genes associated to lipid droplets, Cidec (Cell-death Inducing 
DFFA-like Effector c), Plin2 (Perilipin 2), Fitm1 (Fat-storage Inducing 
Transmembrane protein 1) and G0S2 (G0/G1 switch 2), was upregulated upon 
Hdac3 knock out, suggesting that lipid sequestration in droplets prevented both 
lipotoxicity and lipid-driven insulin resistance in the liver. In addition, hepatic 
Ncor knock out showed similar lipid and metabolic phenotype, indicating the 
importance of coregulators recruitment for HDAC3 activity in the liver (Sun et al. 
2013). 
HDAC3 is a key regulator of energy metabolism also in the heart (Montgomery 
et al. 2008). Cardiomyocyte-specific Hdac3 deletion induced cardiac hypertrophy 
and fibrosis, resulting in cardiac dysfunction and in lethality by 16 weeks of age. 
Cardiac hypertrophy was caused by increased activation of PPARα target genes 
(Pdk4, Acadl, Acadvl, Acox, Ucp2 and Ucp3), thus increasing fatty acid oxidation 
potential and mitochondrial uncoupling. In fact, the authors showed that in wild 
type mice PPARα and HDAC3 were co-recruited and repressed gene expression, 
while, upon Hdac3 gene deletion, PPAR-responsive elements increased H3 
acetylation and the expression of target genes was induced. In addition, another 
study adopted a murine model with Hdac3 ablation in cardiac and skeletal muscle 
only after birth by means of Mck-Cre mice (muscle creatine kinase promoter) 
(Sun et al. 2011). This murine model did not show abnormalities when fed 
normal diet, but displayed severe cardiac contractile dysfunction and hypertrophic 
cardiomyopathy on HFD, leading to heart failure and lethality. Indeed, heart 
Hdac3 knock out impaired fatty oxidation potential that resulted detrimental upon 
dietary lipid overload.  
The same group has recently generated a mouse model with Hdac3 ablation in 
skeletal muscle (HDAC3-SkMKO), by means of MLC-Cre mouse (myosin light 
chain 1f promoter) (Hong et al. 2016). HDAC3-SkMKO mice showed systemic 
insulin resistance and glucose intolerance. Moreover, glucose uptake was reduced 
upon exercise with concomitant increase in anaplerotic flux from amino acid 
metabolism. However, HDAC3-SkMKO mice showed enhanced endurance, 
possibly due to increased mitochondrial oxidative capacity. Indeed, HDAC3-
SkMKO mice displayed increased fatty acid oxidation and reduced RER, 
indicating fuel preference switch towards fatty acids. This increased preference of 
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fatty acids as energy source was due to increased amino acid catabolism, 
particularly that related to branched chain amino acids (BCAAs), and increased 
anaplerosis via purine nucleotide cycle. By using different “omics” approaches, the 
authors demonstrated that REV-ERBα recruited HDAC3 during late afternoon 
to enhancers, thus inducing HDAC3-mediated repression of metabolic genes. In 
fact, metabolic genes repressed by HDAC3-REV-ERBα complex showed 
circadian rhythmicity in expression patterns. Overall, the authors proposed a 
model whereby in nocturnal animals the circadian clock dissociates HDAC3 from 
metabolic genes just before the start of light and fasting period, thus activating 
BCAA catabolism and anaplerosis, lipid oxidation and mitochondrial oxidative 
capacity and concurrently reducing glycolysis. This mechanism spares glucose for 
brain and red blood cells. Conversely, before night and feeding period, REV-ERB 
recruits HDAC3 to the genome, thus inducing glucose utilization in skeletal 
muscle.  
Finally, the same authors showed results from generation of Hdac3 knock out 
specifically in BAT (Emmett et al. 2017). Loss of Hdac3 resulted in impaired 
thermogenic response upon cold exposure and mitochondrial dysfunction, leading 
to lethality upon cold. In fact, HDAC3 KO BAT displayed repression of genes 
important for oxidative phosphorylation, TCA cycle, energy and metabolic 
pathways, among which Ucp1. The authors observed upon Hdac3 ablation reduced 
H3K27ac near repressed genes and increased H3K27ac peaks near upregulated 
genes. De novo motif analyses identified that HDAC3 coactivated ERRα, thus 
inducing the thermogenic program in BAT. Moreover, HDAC3 activated 
PGC1α (Ppargc1a, PPARγ Coactivator 1 a) both transcriptionally and via lysine 
deacetylation. Considering that PGC1α is indispensable for ERRα-driven gene 
expression, these data indicated that HDAC3 strengthened ERRα-driven gene 
expression also activating its partner PGC1α. By observing gene expression at 
thermoneutrality and at room temperature (RT), the authors concluded that BAT 
HDAC3 is required to maintain minimal basal expression of Ucp1 and metabolic 
genes so that BAT thermogenesis is readily activated to maintain body 
temperature upon cold exposure.  
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Aim of the study 
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Recently obesity has been described as epidemic: it has been, in fact, estimated 
that over 50% of European people are overweight or obese. Obesity is often 
accompanied by a plethora of comorbidities such as insulin resistance and type II 
diabetes, metabolic syndrome, neurological dysfunctions and increased prevalence 
of cancer. This pathological condition is also considered one of the major risk 
factors for cardiovascular diseases. For these reasons, obesity has become an 
urgent and worrisome health problem. To face this important challenge, many 
researchers worldwide have focused their scientific interest in the study of the 
pathophysiology of adipose tissues. Adipose tissue is a complex organ and 
metabolic homeostasis is maintained by a physiologic interplay between different 
cellular actors: adipocytes, regulatory immune cells and others. This fine-tuned 
communication is altered as a consequence of diets enriched in fat, causing a low-
grade inflammatory condition, defined "metaflammation", which results 
detrimental for whole body metabolism and health status. The discovery that it is 
possible to induce thermogenic capacity of adipose tissue opened a new era for 
scientific investigations in the metabolic field. Firstly, it is common knowledge 
that brown adipose tissue contributes to non-shivering thermogenesis, burning 
fatty acids and dissipating energy as heat. However, it has been described that 
specific environmental cues, i.e. cold, can induce thermogenesis even in white 
adipose tissue, a phenomenon called browning (Kajimura et al. 2015). Upon 
exposure to these stimuli, specific adipocytes, interspersed within WAT, acquire 
metabolic characteristics of brown fat cells (e.g., thermogenesis). The induction of 
browning in animal models of obesity reduced body weight and ameliorated 
whole body metabolic dysfunctions (Rosen & Spiegelman 2013). This discovery 
shed a new light to find new promising therapeutic strategies to fight obesity. 
How environment interferes with functions of metabolic organs has gained more 
and more attention. Epigenetic mechanisms lead to adapt genomic functions to 
changed environmental conditions. Epigenetic machinery takes advantages of 
enzymes and regulatory proteins that dynamically modulate chromatin 
architecture so that gene expression and cellular function can be rapidly and finely 
regulated in response of external stimuli. Moreover, epigenetic enzymes use as 
cofactors or substrates metabolic intermediates, thus metabolism and epigenetics 
may be reciprocally and simultaneously regulated (Ferrari et al. 2018). At this 
regard, a huge amount of scientific publications is focused on the role of different 
epigenomic modifiers in regulating whole body or tissue specific metabolism. One 
of the epigenomic modifiers’ family intensely investigated includes histone 
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deacetylases (HDACs). HDACs catalyse the removal of acetyl groups from lysine 
residues of histone tails, thus leading to increased chromatin condensation and 
repression of gene transcription. Their activity is counterbalanced by histone 
acetyltransferases (HATs), which catalyse the opposite reaction and therefore 
induce chromatin relaxation and gene activation. HDACs are also recruited with 
coregulators of transcription as part of protein complexes that may also modulate 
proximity of regulatory genomic regions to genes. HDACs are divided in four 
classes according to their homology to yeast HDACs. Several groups 
demonstrated that HDACs regulate energy homeostasis and metabolism in 
several organs (Montgomery et al. 2008; Knutson et al. 2008; Sun et al. 2012; Sun 
et al. 2011; Clearance et al. 2016; Emmett et al. 2017; Ferrari et al. 2012). At this 
regard, our laboratory demonstrated that inhibition of class I HDACs strongly 
ameliorated metabolic phenotype in models of obesity (Galmozzi et al. 2013; A. 
Ferrari et al. 2017). Treatment with MS-275, class I HDAC specific inhibitor, 
caused reduction of body weight (Figure 14a) in diet-induced obese mice (DIO 
mice) and db/db mice (data not shown). Moreover, it has also been observed an 
amelioration of glucose clearance as measured by glucose tolerance test (Figure 
14b). DIO mice treated with MS-275 were able to maintain higher levels of body 
temperature than vehicle-treated mice upon cold exposure (Figure 14c), 
suggesting higher thermogenesis.  
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Figure 14: a) Body weight measurements of DIO mice treated with vehicle or MS-275. 
b) Intraperitoneal glucose tolerance test (ip-GTT) of DIO mice treated with vehicle or 
MS-275. c) Cold challenge of DIO mice treated with vehicle or MS-275. *p<0.05.  
 
This was accompanied by a reduction of subcutaneous WAT mass (Figure 15a), 
adipocyte size (Figure 15b) and increased expression of genes for lipid catabolism 
(Atgl, Cpt1b, Acadl) (Figure 15c) and brown phenotype (Ucp1, Adrb3, Cidea, Dio2, 
Ppara) (Figure 15d), suggesting that MS-275 induced browning of white adipose 
tissue.  
 
 
 
Figure 15: a) SubWAT weight of DIO mice treated with vehicle or MS-275. b) H&E 
staining of DIO mice SubWAT treated with vehicle or MS-275 and related calculation 
of SubWAT cell size. c) SubWAT expression of genes related to lipid metabolism of DIO 
 42 
mice treated with vehicle or MS-275. d) SubWAT expression of browning markers of 
DIO mice treated with vehicle or MS-275. *p<0.05; **p<0.01; ***p<0.001. 
 
Furthermore, another set of experiments demonstrated that only Hdac3 silencing 
in vitro resembled the effects observed in vivo with MS-275 treatment, therefore 
suggesting HDAC3 as the major class I HDAC isoform involved in these 
mechanisms (Figure 16).  
 
Figure 16: silencing of C2C12 myoblasts showed Hdac3 silencing mimicked MS275 in 
vivo treatment. *p<0.05.   
 
Based on these results, the principal aim of my PhD project was to investigate the 
role of HDAC3 in adipose tissue pathophysiology. Our laboratory generated a 
mouse model with specific ablation of Hdac3 in the adipose tissue (H3atKO 
mice). Briefly, by using this in vivo murine model, we discovered that Hdac3 
ablation induced rewiring of metabolism toward a futile cycle of fatty acids usage 
and re-synthesis, that sustained thermogenesis and browning. The rearrengement 
of WAT metabolic phenotype was associated with strong reprogram of gene 
expression with induced oxidative and mitochondrial gene program and activation 
of PPARγ- and PPARα-dependent regulatory networks. Moreover, we also 
conducted in vitro experiments by silencing Hdac3 in C3/H10T1/2 cell line, 
which can be differentiated to adipocytes. In vitro results confirmed in vivo 
findings, establishing a solid tool to deeply investigate molecular mechanisms 
underlying Hdac3 ablation. Thanks to this in vitro model, we demonstrated that 
carbons from fatty acids are used as source for de novo lipogenesis. Moreover, the 
flux of acetyl groups from mitochondria to cytosol and nucleus, controlled by 
ACLY, resulted to be fundamental in these mechanisms. We then exposed 
H3atKO mice to high fat feeding. Surprisingly, we did not observe any difference 
between H3atKO and Floxed (i.e., WT) mice in terms of body weight gain, 
metabolic and molecular features. To explain this unexpected result, we focused 
on regulation of lipid metabolism exerted by high fat diet. As a matter of fact, 
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high fat feeding not only differently regulated PPARs expression and activity but 
also lipogenesis via reduced ChREBPβ expression. The disruption of the 
equilibrium between metabolism and gene regulation of H3atKO blunted the 
effect of Hdac3 ablation. We also explored immunophenotyping of visceral WAT 
in H3atKO mice. FACS analysis demonstrated increased number of monocytes, 
neutrophils and macrophages in H3atKO mice. Furthermore, we also observed 
increased percentage of M1 macrophagic subset. Interestingly, when we exposed 
H3atKO mice to a shorter period of high fat feeding, M1 macrophage levels were 
no further exacerbated by diet exposure. This preliminary observation led us to 
hypothesize that Hdac3 ablation not only strongly impacted metabolism but also 
immune functionality of WAT. Finally, we explored the possibility that HDAC3 
is involved in the physiological induction of browning upon cold exposure. In vivo 
findings demonstrated analogies in terms of gene expression between Hdac3 
ablation and exposure to cold in inguinal WAT. These evidences support the idea 
that HDAC3 can be a novel regulator of adipocyte response to cold. This 
hypothesis has been, at least in part, confirmed by other investigators (Liao et al. 
2018; Yuliana et al. 2018). In conclusion, the results presented in the following 
thesis unravelled novel mechanisms of regulation of adipocyte functionality and 
plasticity. In perspective, possible molecules able to unlock these mechanisms will 
constitute a promising therapeutic approach against obesity and related disorders.  
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In vivo experiments  
Generation of Hdac3 adipose specific knock out mouse model (H3atKO) 
 
All experiments including animal models were conducted following European 
regulations EU Directive 86/609/-CEE and 2010/63/EU and Italian regulations 
DL 116/1992 and 26/2014. Animal protocols used in this study were approved by 
Italian Health Ministry (protocols 06/2012 and 898/2015-PR).  
Hdac3 Floxed mice (Hdac3fl/fl) in C57Bl/6J background, kindly provided by Dr. 
Scott W. Hiebert Laboratory, Vanderbilt University, were crossed with B6; FVB-
Tg (Adipoq-Cre)1Evdr/J mice (The Jackson Laboratory) to obtain Hdac3 adipose 
tissues specific deletion. To identify H3atKO and Floxed mice, tail or ear biopsies 
were collected and DNA was extracted with NucleoSpin Tissue kit (Macherey 
Nagel). PCR with specific primers was performed on DNA extracted. 
Floxed and H3atKO mice at 8 weeks of age were fed standard diet (4rf21 GLP 
certificate, Mucedola), low fat diet (LFD, D12450H, Research Diet) and high fat 
diet (HFD, D12451, Research Diet) for 24 weeks. Body weight was monitored 
before, during and at the end of the diet experiment. At the end of the diet 
exposure, mice were euthanized and blood samples and tissues were collected from 
individual animals. Specifically, inguinal subcutaneous (IngWAT), brown adipose 
tissue (BAT) and epididymal visceral (EpiWat) white adipose tissue were 
collected and snap frozen for following experiments. Plasma triglycerides, NEFA 
and cholesterol levels were measured using commercial kits (respectively Plasma 
Triglycerides Kit -Sentinel, NEFA kit -Wako Chemicals and Plasma Cholesterol 
Kit -Sentinel).  
Cold challenge test 
 
Basal rectal temperature was measured at room temperature (RT) at the 
beginning of the experiment. Then, mice were housed at 4° C and rectal 
temperature was measured every 20 min. LFD fed mice were exposed to 4° C up 
to 24 h, whereas HFD fed mice underwent cold challenge only for 100 min to 
avoid possible hypothermia. To collect IngWAT at 4° C, LFD mice were housed 
at 4°C for 24 hours. After this period mice were euthanized and IngWAT was 
collected at 4° C from individual animals.  
Intraperitoneal glucose tolerance test (ip-GTT) 
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HFD fed mice were fasted for 16 hours. Basal glycaemia was measured at the 
beginning of the experiment using OneTouch Glucometer. Then 1 g/kg glucose 
was intraperitoneally injected and glycaemia was measured 30, 60, 90, 120, 150 
and 180 min after injection. 
Immunophenotyping 
 
Immunophenotyping experiments were performed in collaboration with Prof. 
Catapano and Prof. Norata Laboratory of Lipoproteins, Immunity and 
Atherosclerosis, Università degli Studi di Milano. Floxed and H3atKO mice at 8 
weeks of age were fed LFD and HFD for 4 weeks. Body weight was monitored 
before, during and at the end of the diet experiment. At the end of the diet 
exposure, mice were euthanized and blood and tissues were collected. Fresh 
collected blood was stained after lysis of red blood cells with ACK solution 
(KHCO3 10mM, NH4Cl 150 mM, EDTA 0.1 mM) for 10 minutes at RT. Fresh 
visceral adipose tissues (ViscWAT) were placed on ice in a 6 well plate and cut in 
small pieces in 2 mL of PBS 5% BSA solution, then collagenase (200 mg/ml final 
concentration, NB4 standard grade, Serva) and CaCl2 (5 mM final concentration) 
were added and samples were incubated at 37°C for 40 minutes under agitation. 
Samples were then top up with MACS (PBS, 2% FCS, 2 mM EDTA) and 
filtered on a sterile bandage and subsequently on a 100 µm and 70 µm cells 
strainers. After lysis of red blood cells with ACK for 5 minutes on ice, samples 
were washed, spun and resuspended in antibody mix. All flow cytometry 
antibodies were used at 1:100 dilutions unless otherwise specified, optimal 
antibody concentrations for staining were calculated based on manufacturer 
instructions. For immunophenotyping, cell suspension containing 1x106 cells or 50 
µL of blood were acquired with or Novocyte 3000 (ACEA Biosciences). The 
following anti-mouse antibodies were used: CD4 BV786, CD8 ev655, CD44 PE, 
CD25 PECy7, Ly6C ef450, Ly6G FITC, CD11b Af700, CX3CR1 PerCP 
Cy5.5, CD115 APC, CD62L ev605, CD45 FITC, CD44 ef450, FoxP3 APC, 
F4/80 PE, CD11c APC, CD206 PECy7, MHCII BV650. 
Histology  
 
Tissues were submerged immediately after collection in Carnoy fixation solution 
(60% EtOH 100%, 30% chloroform, 10% glacial acetic acid) and fixed for 24 
hours at 4°C. Tissue were then stored in 100% EtOH at 4°C. Before starting 
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histological analysis, tissues were paraffin embedded and 8 µm sections were 
obtained using microtome. 
Haematoxylin and eosin staining 
 
8 µm sections were deparaffinized and stained with haematoxylin and eosin 
(H&E). 20x magnification images were taken and IngWAT adipocytes cell size 
was quantified using Adobe Photoshop CS6 (Adobe System Inc., San Jose, CA, 
USA).  
Immunohistochemistry  
 
8 µm IngWAT sections were deparaffinized and then incubated with 0,05 M 
NH4Cl for 30 min to retrieve antigens. 20 min incubation with 1% H2O2 was 
performed to block endogenous peroxidase activity, then 1% BSA in 0,1% Triton 
X100 blocking buffer was applied for 1 hour. Anti-UCP1 (Abcam) antibody was 
applied at 1:300 dilution overnight at 4° C. Sections were then incubated with 
biotinylated secondary antibody at 1:3000 dilution. Presence of UCP1 was then 
revealed by DAB reaction.  
Immunofluorescence 
 
8 µm IngWAT sections were deparaffinized and then incubated with 1 N HCl 
for 10 min at 4°C, 2 N HCl for 10 min RT and 20 min at 37 °C to retrieve 
antigens.  5% BSA in 0,1% Triton X100 blocking buffer was applied for 1 hour. 
Anti-ACLY (Abcam) antibody was applied at 1:200 dilution overnight at 4°C. 
Sections were then incubated with AlexaFluor 488 secondary antibody at 1:1000 
dilution to reveal presence of ACLY (green signal). Nuclei were then stained 
using Hoechst solution 1:1000 for 30 minutes (blue signal). 40X magnification 
images were taken and nuclei positive for green signal were counted and divided 
by the total number of nuclei for each section as indication of ACLY nuclear 
localization (n:3 H3atKO mice vs Floxed mice).   
Cell cultures 
 
C3H/10T1/2 cells were purchased from ATCC (CCL-226). For culturing and 
differentiate cells to adipocytes following media were used:  
− Culturing medium: Dulbecco's Modified Eagle's Medium (DMEM, Sigma 
Aldrich) with 10% inactivated Foetal Bovine Serum (FBS, Euroclone), 1% 
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glutamine (Life Technologies), 1% penicillin/streptomycin (Pen/Strep, Life 
Technologies) 
− Differentiation medium:  culturing medium supplemented with 5 µg/ml 
insulin (Sigma Aldrich), 0,5 mM 3-isobutyl-1-methyl-xanthine (IBMX, 
Sigma Aldrich), 5 µM rosiglitazone (Cayman Chemicals) and 2 µg/ml 
dexamethasone (Sigma Aldrich) 
− Maintenance medium: culturing medium supplemented with 5 µg/ml 
insulin (Sigma Aldrich) 
To induce differentiation to mature adipocytes, cells were seeded at 70000 
cells/ml concentration and maintained confluent for 24 hours (day 0). Culturing 
medium was then replaced with differentiation medium for 72 hours (day 3). At 
day 3 differentiation medium was replaced with maintenance medium, which was 
renewed every other day until day 9.  
 
 
Figure 17: treatment scheme of C3H/10T1/2 cell line.  
 
To inhibit PPARα, DMSO (vehicle) or 10 µM GW6471 were added at day 0 
and maintained until day 9.  
In vitro knock down by RNAi 
 
To knock down Hdac3, at day 0 100 MOI Scramble or ShHdac3 adenoviral 
vectors (Vector BioLabs) were added to differentiation medium. To evaluate 
lipolysis, glycerol content in cell medium was measured at day 9 with Triglyceride 
Dosage Kit (Sentinel) and normalized to protein content. 
To knock down Acly and Acss2, at day 0 50 MOI ShAcly or ShAcss2 adenoviral 
vectors (Vector BioLabs) were added to differentiation medium.  
To simultaneously knock down Hdac3 and Acly or Hdac3 and Acss2, at day 0 50 
MOI ShAcly or ShAcss2  + 100 MOI ShHdac3 adenoviruses were added to 
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differentiation medium, using 150 MOI Scramble treated cells as negative 
control.  
13C tracing experiments 
 
At day 9 C3H/10T1/2 Scramble or ShHdac3 treated cells were incubated with 
100 µM [U-13C] palmitate (Sigma Aldrich) and 1 mM carnitine (Sigma Aldrich) 
for 30 minutes at 37 °C. Cells were then washed with cold PBS and lysed with 
MeOH 100 % (LC-MS grade). Extracts were analyzed by electrospray ionization 
flow injection analysis tandem mass spectrometry (FIA-MS/MS). Each 
isotopomer was resolved by m/z ratios and quantitated by Mass Distribution 
Vector (MDV). % MDV was then normalized to protein content. 
Oil Red O staining 
 
Oil Red O (ORO) staining was performed to quantify lipid content in 
C3H/10T1/2 at day 9. C3H/10T1/2 cells were seeded in 12-well plates and 
differentiated as described for 9 days. At the end of differentiation (day 9) cell 
were fixed with 100% formaldehyde for at least 1 hour and then washed with 
H2O. Fixed cells were incubated with 1 ml 60% isopropanol for 2-5 minutes.  
ORO solution was applied for 10 minutes. Stained cells were then washed 3 times 
with 1 ml H2O and images were taken. For quantification ORO was eluted 
incubating with 1,5 ml 100% isopropanol for 10 minutes. Staining absorbance was 
then measured at 500 nm wavelength, 0,5 second of reading. Quantification of 
ORO was normalized to protein content.  
Chromatin-Immunoprecipitation qPCR (ChIP-qPCR) 
 
IngWAT or Scramble and ShHdac3 treated C3H/10T1/2 cells at day 9 were 
cross-linked for 10 min with 1% formaldehyde, which was stopped by addition of 
125 mM glycine solution. Cells and tissue were lysed and chromatin was sheared 
by sonication (SLPe sonicator, Branson). H3K27ac antibody (1 µg, ab4729, 
Abcam) was pre-incubated with 20 µl G protein DynaBeads (Life Technologies) 
for 1 h RT, to allow the binding of the antibody to Dynabeads. Sheared 
chromatin was incubated with Dynabeads solution overnight at 4 °C. After 
reversing crosslinking by incubating overnight at 65 °C, DNA was cleaned on 
QIAquick gel extraction kit columns (QIAGEN). Inputs and 
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immunoprecipitated samples were analyzed by qRT-PCR using gene-specific 
primers. Data are expressed as 10% of input.  
RNA extraction and gene expression  
 
For gene expression analysis, C3H/10T1/2 cells at day 9 or adipose tissues were 
lysed with TRIzol (Invitrogen) or Qiazol Reagent (Qiagen). Cell cultures were 
alternatively lysed with RA1 reagent (Macherey Nagel) supplemented with β-
mercaptoEtOH. RNA from cell cultures extracts was purified with commercial 
kits (NucleoSpin RNA II, Macherey Nagel). RNA from adipose tissues was 
purified with commercial kits (RNeasy Lipid Tissue Mini kit, Qiagen). Total 
RNA was quantified by Nanodrop (Thermo Scientific). Specific mRNA was 
amplified with specific primers and quantitated by Real Time PCR, using SYBR 
Green (iScript One-Step qRT-PCR kit for SYBR Green, Bio-Rad Laboratories) 
or specific TaqMan probes (iScript One-Step qRT-PCR kit for Probes, Bio-Rad 
Laboratories) on CFX384 instrument (Bio-Rad Laboratories). Each specific 
mRNA was normalized to 36b4 RNA. Specific primers and probes were designed 
using IDT software and synthesized by Eurofins MWG Operon. Primers and 
probes for Pparg and Adrb3 were purchased from Applied Biosystems, Thermo 
Fisher Scientific. Gene expression data of C3H/10T/1/2 cells treated with 
Scramble or ShHdac3 were obtained from four independent experiments (n= 4).  
RNA-sequencing 
 
RNA-sequencing (RNA-Seq) analysis of subcutaneous IngWAT was performed 
in collaboration with Dr. Béatrice Desvergne Laboratory, Centre Intégratif de 
Génomique, Université de Lausanne. Analysis was obtained from three pooled 
samples, each of whom contained 500 ng of total RNA from 2-3 individual 
animals. RNA-Seq libraries were prepared with PolyA selection using 500 ng of 
total RNA and the Illumina TruSeq Stranded RNA reagents (Illumina; San 
Diego, CA, USA) on a Sciclone liquid handling robot (PerkinElmer; Waltham, 
MA, USA) using a PerkinElmer developed automated script. Cluster generation 
was performed with the resulting libraries using the Illumina TruSeq SR Cluster 
Kit v3 reagents and sequenced on the Illumina HiSeq 2500 using TruSeq SBS Kit 
v3 reagents. Sequencing data were processed using the Illumina Pipeline Casava 
1.82. Purity-filtered reads were adapted and quality trimmed with Cutadapt (v. 
1.3, and filtered for low complexity with seq_crumbs (v. 0.1.8). Reads were 
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aligned against Mus musculus (version GRCm38) genome using STAR (v. 
2.4.2a). The number of read counts per gene locus was summarized with htseq-
count (v. 0.6.1) using Mus musculus (Ensembl v. GRCm38.82) gene annotation. 
Statistical analysis was performed for genes in R (R version 3.2.3). Genes with 
low counts were filtered out according to the rule of 1 count per million (cpm) in 
at least 1 sample. Library sizes were scaled using TMM normalization (EdgeR 
package version 3.12.1), and log-transformed with limma voom function (Limma 
package version 3.26.9). Differential expression was computed with limma. We 
used DAVID to highlight the biological functions enriched in differentially 
expressed genes. The annotated terms were grouped according to the degree of 
their co-association genes with the functional annotation clustering feature. The 
Group Enrichment Score, namely the geometric mean (in -log scale) of member’s 
p-values in a corresponding annotation cluster, is used to rank their biological 
significance. 
Protein analysis 
 
Reagents and buffers 
− SDS Sample Buffer 2x: 100 mM TrisHCl pH 6.8, 20% glycerol, 4 % SDS, 
100 mM dithiothreitol, 0,002% BBF, protease inhibitor 1X (Sigma 
Aldrich) 
− Blocking buffer: 5% non-fat milk in TBS 1X + 0,1 % Tween-20 
− Washing buffer: TBS 1X + 0,1 % Tween-20  
− Antibody dilution buffer: TBS 1X + 0,1 % Tween-20 
− Secondary antibodies: horse radish peroxidase-conjugated goat anti-mouse 
(Sigma-Aldrich) or horse radish peroxidase-conjugated goat anti-rabbit 
(Cell Signaling) 
 
C3H/10T1/2 at day 9 and adipose tissues (IngWAT, EpiWAT and BAT) were 
disrupted with SDS SampleBuffer 2x on Tissue Lyser (Qiagen) and suitable 
beads. After centrifugation, appropriate amount of samples was incubated at 95°C 
for 5 min and immediately put on ice. Samples were separated on SDS-PAGE 
and then electro-transferred to nitrocellulose membranes. Proper transfer of 
proteins on nitrocellulose membranes was checked by Ponceau staining. Blocking 
buffer was then added to membranes for 1 hours RT with gentle agitation. 
Primary antibodies were then added at proper dilutions overnight at 4°C with 
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gentle agitation. Membranes where then washed with washing buffer and 
incubated with secondary antibodies at proper dilutions for 1 hour RT with gentle 
agitation. Detection of proteins was performed with ECL Chemiluminescence 
(Pierce). Quantification of proteic bands on films was performed using ImageJ 
software and normalized to loading control proteins.  
Analysis of metabolome by mass spectrometry 
 
Subcutaneous inguinal and visceral epididymal fat were disrupted with Tissue 
Lyser (Qiagen), after addition of MeOH and suitable beads. For each sample an 
aliquot of methanolic extracts was used to quantify acylcarnitines and metabolites. 
This aliquot was subjected to analysis in the positive ion mode by electrospray 
ionization flow injection analysis, using O-Propionyl-L-carnitine-HCl-D3,C3 as 
internal standard. Another aliquot of methanolic extracts was used to quantify 
total fatty acids: after addition of heneicosanoic acid (C21:0) and 13C-linoleic acid 
(Sigma Aldrich), as internal standards, it was subjected to acidic hydrolysis and 
processed for quantification. For acylcarnitines and fatty acid analysis API-4000 
triple quadrupole mass spectrometer (AbSciex) coupled with HPLC system 
(Agilent) and CTC PAL HTS autosampler (PAL System) were used. 
Metabolites level was then normalized on protein content.  
Statistical analyses 
  
Statistical analyses were performed using the unpaired two- tailed Student’s t-test, 
one way ANOVA or two way ANOVA, with Tukey’s as post hoc test, with 
GraphPad PRISM (San Diego, CA, USA).  
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Results 
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Adipose tissue - specific Hdac3 knock out promotes browning  
 
Recently it has been reported that HDACs regulate metabolism and energy 
homeostasis in different tissues. We have previously demonstrated that inhibition 
of class I HDACs reduced body weight and ameliorated glucose tolerance in 
obese mice. Class I HDAC inhibitor, MS-275, induced browning of white 
adipose tissue. Moreover, silencing experiments suggested HDAC3 as a key 
player in mechanisms exerted by MS-275. For these reasons, we generated a 
murine model with Hdac3 adipose ablation (H3atKO mice) by means of Cre-
LoxP technology. We chose Adipoq-Cre mice to obtain adipose-specific knock 
out. H3atKO mice and Floxed littermates (controls) were fed low fat diet (LFD) 
for 24 weeks. Western blot analysis confirmed Hdac3 knock out in adipose tissues 
(Figure 18).  
 
 
Figure 18: western blotting of HDAC3, showing deletion of Hdac3 in IngWAT and 
related quantification (a), EpiWAT (b) and BAT (c) in H3atKO vs Floxed mice. 
Statistical analysis: Student’s t test; **p<0.01 vs Floxed mice.  
 
H3atKO mice showed no differences in terms of body weight gain (Figure 19a). 
However, H3atKO mice displayed reduced visceral EpiWAT (Figure 19c) and a 
mild reduction of subcutaneous inguinal IngWAT (Figure 19b).  
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Figure 19: a) Body weight gain of Floxed and H3atKO mice. b) Subcutaneous 
IngWAT weight of Floxed and H3atKO mice. c) Epididymal WAT weight of Floxed 
and H3atKO mice. Student’s t test; ***p<0.001 vs Floxed mice.  
 
Most importantly, IngWAT of H3atKO mice appeared reddish, suggesting 
higher number of mitochondria (Figure 20a). H&E staining revealed increased 
number of multilocular adipocytes (Figure 20b-c), typical of brown adipose tissue, 
with no reduction of adipocyte size (Figure 20d). IHC analysis demonstrated 
increased UCP1 staining in IngWAT of H3atKO, which corresponds to 
increased UCP1 expression (Figure 20e), thus suggesting higher thermogenic 
capacity of H3atKO mice. This data was, in fact, paralleled by cold challenge test 
which showed increased capacity of H3atKO mice to maintain body temperature 
during 24 hours of exposure to 4°C (Figure 20f).  
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Figure 20: a) IngWAT of Floxed and H3atKO mice. b) IngWAT H&E staining of 
Floxed vs H3atKO mice. Scale bar is 100 µm. c) Number of multilocular adipocytes in 
IngWAT of Floxed vs H3atKO mice. d) Adipocyte size quantification of Floxed vs 
H3atKO mice. e) IHC staining of UCP1 in IngWAT of Floxed vs H3atKO mice. Scale 
bar is 100 µm. f) Body temperature measurements of Floxed vs H3atKO mice exposed to 
4°C for 24 h and related area under curve (AUC). Student’s t test; *p<0.05; **p<0.01; 
***p<0.001 vs Floxed mice.   
 
Regarding plasma lipids, we detected reduced levels of triglycerides (Figure 21a), 
non-esterified fatty acids (NEFA) (Figure 21b), with no difference in cholesterol 
(Figure 21c). Taken together, these data clearly showed induction of browning in 
IngWAT upon Hdac3 ablation. 
 
 
Figure 21: levels of plasma lipids in Floxed vs H3atKO mice, in particular triglycerides 
(a), NEFA (b) and cholesterol (c). Student’s t test; *p<0.05; ***p<0.001 vs Floxed mice.   
Hdac3 ablation reprograms gene expression in white adipose tissue 
 
Considering that HDAC3 is an epigenomic regulator of gene expression, we 
decided to perform RNA-Sequencing analysis in IngWAT in collaboration with 
Dr. Béatrice Desvergne Laboratory, University of Lausanne.  To this end, we 
analysized transcriptome in H3atKO and Floxed mice fed standard diet. We 
found 2246 downregulated and 1429 upregulated genes, indicating that Hdac3 
knock out did not increase globally gene expression (Figure 22a-b). Moreover, 
upregulated genes belonged to functional annotations related to mitochondria, 
fatty acid metabolism, respiratory chain and oxidoreductase activity, suggesting 
that Hdac3 ablation induced lipid and oxidative gene program in IngWAT. 
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Figure 22: RNA-Seq analysis of Floxed and H3atKO IngWAT. a) Downregulated 
genes. b) Upregulated genes.  
 
Therefore, to confirm these data we performed qPCR in H3atKO and Floxed 
mice fed LFD for 24 weeks IngWAT. We detected increased expression of genes 
important for adipocyte functionality (Pparg, Fabp4, Adipoq, Glut4, Plin) (Figure 
23a) and TCA cycle and oxidative metabolism (Idh3a, Bckdhb, Cox7a1, Ppargc1-a) 
(Figure 23b). Furthermore, we found strongly increased expression of browning 
genes (Ucp1, Dio2, Ppara, Prdm16, Adrb3, Vegfa) (Figure 23c).  
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Figure 23: gene expression analysis by qPCR in Floxed vs H3atKO IngWAT. a) 
Adipocyte functionality and differentiation genes. b) Genes related to oxidative 
metabolism. c) Browning markers. Student’s t test; *p<0.05; **p<0.01; ***p<0.001 vs 
Floxed mice.   
 
These data suggested that Hdac3 knock out reprogrammed gene expression 
toward lipid and oxidative metabolism. With respect to visceral EpiWAT, we 
found similar results upon Hdac3 knock out, though in a smaller degree. In fact, 
there was no difference in terms of histology and number of multilocular 
adipocytes, but increased expression of adipocyte markers, browning and oxidative 
metabolism genes was observed also in EpiWAT.  
 
 
Figure 24: a) EpiWAT H&E staining of Floxed and H3atKO mice. Scale bar is 100 
µm. b, c, d) Gene expression of adipose markers (a), browning markers (b) and oxidative 
metabolism genes (d) in EpiWAT of Floxed and H3atKO mice. Student’s t test; 
*p<0.05; ***p<0.001 vs Floxed mice.  
Hdac3 adipose knock out rewires metabolism 
 
Transcriptome analysis revealed that Hdac3 knock out induced gene program 
linked to lipid and oxidative metabolism. Therefore, we analysed metabolites level 
in IngWAT. As indicated by heatmap of metabolites (Figure 25), H3atKO mice 
displayed metabolic remodelling with metabolite levels globally reduced versus 
Floxed mice.  
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Figure 25: heatmap of metabolite levels in IngWAT of Floxed and H3atKO mice.  
 
Volcano plot showed citrate as the most reduced metabolite upon Hdac3 ablation 
(Figure 26a). In fact, we detected a strong reduction of citrate levels, along with 
that of acetyl-CoA (Figure 26b). The striking reduction of citrate prompted us to 
investigate more in depth citrate synthesis in H3atKO mice. As a matter of fact, 
we found increased expression of Cs (citrate synthase), suggesting higher citrate 
condensation, paralleled by increased expression of Slc25a1, which exports citrate 
out of mitochondrion, and Acly, which catalyzes the enzymatic conversion of 
citrate to citosolic oxaloacetate and acetyl-CoA (Figure 26c). These data 
suggested increased utilization of citrate in IngWAT of H3atKO mice.  
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Figure 26: a) Volcano plot of IngWAT metabolites. b) Acetyl-CoA and citrate levels in 
IngWAT of Floxed and H3atKO mice. c) Expression of genes related to citrate 
metabolism in IngWAT of Floxed and H3atKO mice. Student’s t test; *p<0.05; 
***p<0.001 vs Floxed mice.  
 
One of citrate possible sources is the mitochondrial conversion of glycolitic 
pyruvate to acetyl-CoA, catalyzed by pyruvate dehydrogenase complex (PDH), 
and the following condensation of acetyl-CoA and oxaloacetate. Therefore, we 
moved to investigate glicolysis and glucose metabolism. Glucose and glycolitic 
intermediates glucose 6-phosphate, fructose 1,6-bisphosphate and 
dihydroxyacetone phosphate/glyceraldehyde phosphate (DHAP/GAP) were 
reduced in H3atKO mice (Figure 27a), suggesting higher glycolitic flux and 
metabolite consumption. In parallel, we found increased expression of pyruvate 
kinase (Pkm) (Figure 27b), which generates pyruvate, but also increased expression 
of pyruvate dehydrogenase kinase 4 (Pdk4), which blocks PDH by phosphorylation. 
In fact, we found increased phosphorylation of PDH at Ser293 and Ser300 in 
IngWAT of H3atKO mice (Figure 27c), suggesting that pyruvate conversion to 
acetyl-CoA is inhibited upon Hdac3 ablation. Increased expression of Mpc1, Pcx 
and Pck1 (Figure 27b) suggested that glycolitic pyruvate is preferentially converted 
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to anaplerotic oxaloacetate, which can be also used to feed glycolysis via 
conversion to phosphoenolpyruvate by PCK1.  
 
 
Figure 27: a) Levels of glycolytic intermediates in IngWAT of Floxed and H3atKO 
mice. b) Expression of genes related to glucose metabolism in IngWAT of Floxed and 
H3atKO mice. c) Phosphorylation of Ser293 and Ser300 PDH analyzed by Western 
Blotting and related quantification in IngWAT of Floxed and H3atKO mice. Student’s 
t test; *p<0.05 vs Floxed mice.   
 
Considering that glucose is not preferentially used to synthesize citrate in 
H3atKO mice, another possible source of mitochondrial acetyl-CoA is fatty acid 
β-oxidation. We, therefore, moved to analyze lipid metabolism. Mass 
spectrometry analysis revealed decreased levels of both saturated and unsatured 
fatty acids in IngWAT of H3atKO mice (Figure 28a). Importantly, we also found 
decreased levels of malonyl-CoA (Figure 28b), which in the mitochondria 
negatively modulates β-oxidation via CPT1 inhibition. Actually, in this case it is 
not possible to discriminate between mitochondrial or cytosolic malonyl-CoA. 
Even though, it is possible to speculate that β-oxidative flux was not reduced by 
malonyl-CoA mediated inhibition.  
 
 62 
 
Figure 28: a) Analysis of fatty acids levels in IngWAT of Floxed and H3atKO mice. b) 
Malonyl-CoA levels in IngWAT of Floxed and H3atKO mice. Student’s t test; *p<0.05 
vs Floxed mice.   
 
In parallel, we found increased expression of genes important for lipolysis (Lipe, 
Atgl) and β-oxidation (Acsl1, Acox1, Cpt1b, Slc25a20, Acadl, Acadm, Hadh) (Figure 
29a). This was confirmed also at protein level for ATGL and ACADL (Figure 
29b). These data suggested that β-oxidation was highly active upon Hdac3 
ablation and that this metabolic route was preferentially used as source for 
synthesizing citrate. However, we detected increased expression of genes 
important for de novo fatty acid synthesis, among which ChREBPβ, the master 
regulator of lipogenesis in the adipose tissue (Figure 29c).  
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Figure 29: a) Expression of genes related to lipolysis and fatty acid β-oxidation in 
IngWAT of Floxed and H3atKO mice. b) ATGL and ACADL Western Blotting and 
related quantification in IngWAT of Floxed and H3atKO mice. c) Expression of 
lipogenic genes in IngWAT of Floxed and H3atKO mice. Student’s t test; *p<0.05; 
**p<0.01; ***p<0.001 vs Floxed mice.  
 
Consequently, we hypothesized that citrate is exported from mitochondria and 
converted by ACLY to cytoplasmic acetyl-CoA which, in turn, is precursor for 
fatty acid synthesis. This hypothesis could explain reduced levels of citrate in 
H3atKO mice IngWAT.  
In vitro Hdac3 silencing recapitulates H3atKO phenotype  
 
We have observed that Hdac3 ablation in vivo caused a deep metabolic 
remodelling. Peculiar of H3atKO metabolic phenotype was the concomitant 
activation of lipolysis and fatty acid β-oxidation and lipogenesis, at least at gene 
expression and metabolite levels. To further confirm these data and deepen 
molecular mechanisms underlying H3atKO phenotype, we set up an in vitro 
model. We used C3H/10T1/2 mesenchimal stem cell line that can be 
differentiated to mature adipocytes. We silenced Hdac3 at the beginning of 
differentiation protocol (day 0) with adenoviral vectors containing short hairpin 
sequences (ShHdac3). Empty adenoviral vectors were used as control (Scramble). 
After 9 days of differentiation, we confirmed by western blot effective Hdac3 
silencing (Figure 30).  
 
 
Figure 30: western blotting confirmed Hdac3 silencing in C3H/10T1/2 cell line.   
 
ShHdac3 infected cells showed increased expression of adipocyte differentiation 
and functionality markers (Pparg, Fabp4, Adipoq, Glut4, Plin, C/EBPα) (Figure 
31a). In fact, after Hdac3 silencing we detected higher number of differentiated 
cells (Figure 31b) and more lipid accumulation as assessed by ORO staining 
(Figure 31c).  
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Figure 31: a) Gene expression of adipocyte functionality markers in Scramble vs 
ShHdac3 treated C3H/10T1/2 cells. b) Morphology of Scramble vs ShHdac3 treated 
C3H/10T1/2 cells. Scale bar is 50 µm. c) Oil Red O staining in Scramble vs ShHdac3 
treated C3H/10T1/2 cells and related quantification. Scale bar is 100 µm. Student’s t 
test; *p<0.05; **p<0.01; ***p<0.001 vs Scramble.   
 
Moreover, ShHdac3 treated cells displayed increased expression of browning 
genes (Ucp1, Adrb3, Ppara, Prdm16, Cidea, Elovl3) (Figure 32).  
 
Figure 32: gene expression of browning markers in Scramble vs ShHdac3 treated 
C3H/10T1/2 cells. Student’s t test; *p<0.05 vs Scramble.   
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Considering expression of metabolic genes, qPCR analysis showed increased 
expression of genes important for glucose and citrate metabolism (Pkm2, Pdk4, 
Mpc1, Pcx, Cs, Acly, Slc25a1, Acss2) (Figure 33a), lipolysis and fatty acid β-
oxidation (Cd36, Lpl, Lipe, Atgl, Acadl, Acadm, Hadh, Cpt1b) and de novo 
lipogenesis (ChREBPβ, Srebf1c, Acly, Fasn, Acaca, G6pd2) (Figure 33b), similarly 
to what observed in vivo.  
 
Figure 33: a) Expression of glucose and citrate metabolism related genes in Scramble vs 
ShHdac3 treated C3H/10T1/2 cells. b) Expression of lipid futile cycle related genes in 
Scramble vs ShHdac3 treated C3H/10T1/2 cells. Student’s t test; *p<0.05; **p<0.01; 
***p<0.001 vs Scramble.  
 
Taken together, these results demonstrated that ShHdac3 cells presented similar 
phenotypical features observed in H3atKO mice and that this in vitro model can 
be used as a tool for examining molecular mechanisms underlying Hdac3 
inactivation in adipose tissue.  
13C labelling experiments confirms fatty acid futile cycle upon Hdac3 
silencing 
 
Concurrent activation of fatty acid β-oxidation and lipogenesis was demonstrated 
to occur both in vivo in H3atKO mice and in vitro in ShHdac3 treated cells at 
level of gene expression and metabolites. Therefore, to further confirm these 
results, we treated ShHdac3 and Scramble cells with [U-13C]palmitate at the end 
of differentiation. Firstly, we measured increased glycerol release in ShHdac3 
treated cells, as result of increased triglycerides hydrolysis. (Figure 34).  
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Figure 34: measurement of glycerol release in Scramble (white bar) vs ShHdac3 treated 
C3H/10T1/2 cells (black bar). Student’s t test; ***p<0.001 vs Scramble.   
 
After [U-13C]palmitate treatment, we analysed by mass spectrometry metabolites 
isotopomers. With respect to citrate, we found decreased levels of citrate + 1 
(Figure35). 
 
Figure 35: levels of citrate +1, +2, +4, +5 isotopomers in Scramble (white bar) vs 
ShHdac3 treated C3H/10T1/2 cells (black bar). Student’s t test; **p<0.01; ***p<0.001 
vs Scramble.   
 
This isotopomer is formed after three rounds of TCA cycle: the first one 
incorporates 2 13C from labelled palmitate to citrate, forming citrate + 2, whose 
levels were not changed upon Hdac3 silencing (Figure 35). In the second round of 
TCA cycle two C from not labelled (cold) palmitate are added to oxaloacetate + 2, 
forming citrate + 2; then 1 13C carbon exits TCA cycle as CO2 (Figure 36).  
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Figure 36: schematic representation of  13C incorporation in metabolite isotopomers from 
labeled palmitate.  
 
Finally, in the third round two C from unlabelled or cold palmitate are added to 
resulting oxaloacetate + 1, forming citrate + 1. This isotopomer then can exit 
TCA cycle and it can be used as substrate by ACLY to produce acetyl-CoA + 1 
(Figure 37).   
 
Figure 37: schematic representation of  13C incorporation in metabolite isotopomers from 
labeled palmitate.  
 
In fact, we found increased levels of acetyl-CoA + 1 isotopomer. The concurrent 
reduction of citrate + 1 and increase of acetyl-CoA + 1 indicated higher ACLY 
activity in ShHdac3 treated cells (Figure 38).  
 
 68 
 
Figure 38: levels of acetyl-CoA + 1 and acetyl-CoA + 2 isotopomers in Scramble (white 
bar) vs ShHdac3 treated C3H/10T1/2 cells (black bar). Student’s t test; **p<0.01 vs 
Scramble.   
 
We also detected increased levels of citrate + 4 (Figure 35), which is formed after 
two rounds of TCA cycle with two following additions of 2 13C from labelled 
palmitate to oxaloacetate (Figure 39).  
 
Figure 39: schematic representation of  13C incorporation in metabolite isotopomers from 
labeled palmitate.  
 
This data suggested increased flux of fatty acid β-oxidation and TCA cycle in 
Hdac3-silenced cells. Furthermore, levels of palmitate + 2 (Figure 40a-c) were 
increased in ShHdac3 treated cells paralleled by a mild increase, though not 
statistically significant, of malonyl-CoA + 2, + 3 isotopomers (Figure 40b).  
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Figure 40: levels of palmitate + 2 (a) and malonyl-CoA + 1, + 2, + 3 (b) isotopomers in 
Scramble (white bar) vs ShHdac3 treated C3H/10T1/2 cells (black bar). c) Schematic 
representation of 13C incorporation in metabolite isotopomers from labeled palmitate. 
Student’s t test; ***p<0.001 vs Scramble.   
 
These results suggested increased de novo lipogenesis with acetyl-CoA from 
palmitate used as precursor. Taken together, these data highlighted increased 
lipolysis, fatty acid β-oxidation and TCA cycle upon Hdac3 silencing. Acetyl-CoA 
from β-oxidation is used as source for de novo fatty acid synthesis via increased 
ACLY activity. This highlighted the onset of futile cycle of fatty acid utilization 
and resynthesis in ShHdac3 treated cells.  
Hdac3 ablation increases histone acetylation in specific chromatin 
regions  
 
Hdac3 ablation in adipose tissue caused browning of WAT, accompanied by the 
onset of fatty acids futile cycle. Rewiring of lipid metabolism was paralleled by 
transcriptional reprogramming. These results prompted us to deepen molecular 
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mechanisms underlying these effects. HDAC3 belongs to a family of enzymes 
that regulate histone acetylation. It has been showed that Hdac3 deletion caused 
hyperacetylation on specific chromatin regions with no increased global histone 
acetylation (Montgomery et al. 2008). Our data were in agreement with this 
previous finding (data not shown). Moreover, it has been reported the presence of 
a Pparg enhancer marked by acetylation on lysine 27 of histone H3 (H3K27ac) in 
white adipose tissue (Ramlee et al. 2014). Another study reported that in 
differentiated brown adipocytes two enhancers located at -13 and -5 kb upstream 
TSS of Ucp1 are acetylated (Abe et al. 2015). Therefore, we decided to perform 
ChIP-qPCR on IngWAT of Floxed and H3atKO mice. We found increased 
acetylation at Pparg enhancer and at -5kb Ucp1 enhancer of H3atKO mice (Figure 
41a). This result was confirmed also in vitro where we detected increased 
acetylation at Pparg enhancer and at both -13 and -5kb Ucp1 enhancers in 
ShHdac3 versus Scramble treated C3/H10T1/2 differentiated adipocytes (Figure 
41b).  
 
Figure 41: a) ChIP-qPCR of H3K27ac at Pparg and Ucp1 enhancers in IngWAT of 
Floxed vs H3atKO mice. Student’s t test; *p<0.05; **p<0.01 vs Floxed mice. b) ChIP-
qPCR of H3K27ac at Pparg and Ucp1 enhancers in Scramble vs ShHdac3 treated 
C3H/10T1/2 cells. Student’s t test; *p<0.05 vs Scramble.   
 
 71 
Furthermore, by analyzing already published ChIP-Seq experiments 
(GSE63964), we observed the presence of H3K27ac peaks at -15, -11, -3.5 and -
1.6 kb upstream from Ppara coding region in BAT samples that were absent in 
WAT samples. Considering that H3K27ac generally marks active enhancers, we 
considered these regions as putative elements regulating Ppara transcription in 
BAT. We hypothesized that hyperacetylation at these regions could be present 
also in WAT during browning. Therefore, we investigated these chromatin 
regions in our model. As a matter of fact, we measured increased H3K27ac at -15, 
-11 and -1.6 kb regions in H3atKO IngWAT (Figure 42a). This result was again 
confirmed also in vitro where hyperacetylation was found at -15 and -11 kb 
putative regulatory regions in ShHdac3 treated cells (Figure 42a).  
 
 
Figure 42: a) ChIP-qPCR of H3K27ac at Ppara putative regulatory regions in 
IngWAT of Floxed vs H3atKO mice. Student’s t test; *p<0.05 vs Floxed mice. b) ChIP-
qPCR of H3K27ac at Ppara putative regulatory regions in Scramble vs ShHdac3 
treated C3H/10T1/2 cells. Student’s t test; *p<0.05; **p<0.01 vs Scramble. 
 
These data indicated that Hdac3 ablation remodelled chromatin in specific 
regions. Hyperacetylation in these regions consequent to Hdac3 ablation increased 
the expression of Pparg, Ucp1 and Ppara, key genes in H3atKO phenotype.  
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ACLY is fundamental for H3atKO phenotype  
 
Hdac3 ablation caused hyperacetylation of Pparg, Ucp1 and Ppara regulatory 
regions. At this regard, it has been recently demonstrated that in the nucleus 
ATP-citrate lyase provides acetyl groups for histone acetylation. In our model we 
found increased Acly expression. However qPCR did not distinguish between 
cytosolic and nuclear ACLY. Therefore, we performed IF experiments in 
IngWAT from Floxed and H3atKO mice. We found increased nuclear ACLY 
localization in H3atKO mice (Figure 43). 
 
 
Figure 43: ACLY immunofluorescence analysis in IngWAT of Floxed and H3atKO 
mice and related quantification of ACLY nuclear localization. Scale bar is 40 µm. 
Student’s t test; *p<0.05 vs Floxed mice.   
 
This data suggested that ACLY had a dual role in H3atKO metabolism: it 
supplied cytosolic acetyl-CoA for fatty acid synthesis and, on the other hand, it 
sustained hyperacetylation of Pparg, Ucp1 and Ppara regulatory regions, by 
providing nuclear acetyl-CoA. To deepen ACLY role in mechanisms exerted by 
adipose Hdac3 ablation, we decided to co-silence Hdac3 and Acly in C3H/10T1/2 
cells at day 0 of differentation. Western blot analysis confirmed that ShAcly 
treatment abolished Acly expression (Figure 44).  
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Figure 44: western blotting confirmed Acly silencing in C3H/10T1/2 cell line.  
 
At the end of differentation, both ShAcly and ShHdac3 + ShAcly co-silenced 
cells appeared less differentiated compared to Scramble or ShHdac3 treated cells 
(Figure 45c). Importantly, co-silencing reduced H3K27 acetylation at Pparg 
enhancer (though not statistical significant), at -5 kb Ucp1 enhancer and at -15, -
11 kb Ppara putative regulatory regions compared to ShHdac3 treated cells 
(Figure 45b). In fact, upregulation of key genes Ucp1, Ppara, Pparg, Glut4, Pdk4, 
Pcx, Atgl, Acadl, Fasn in ShHdac3 treated cells was prevented by Acly silencing 
(Figure 45c).  
 
Figure 45: a) Morphology of Scramble, ShHdac3, ShAcly and ShHdac3 + ShAcly treated 
C3/H10T1/2 cells. Scale bar is 50 µm. b) ChIP-qPCR of H3K27ac at Pparg and Ucp1 
enhancers and Ppara putative regulatory regions in ShHdac3 and ShHdac3 + ShAcly 
treated C3/H10T1/2 cells. Student’s t test; *p<0.05; **p<0.01; ***p<0.001 vs ShHdac3. 
c) Expression of genes important for metabolic rewiring upon Hdac3 ablation in 
Scramble, ShHdac3, ShAcly and ShHdac3 + ShAcly treated C3/H10T1/2 cells. One 
way ANOVA, Tukey as post hoc test; **p<0.01, ***p<0.001 vs. Scramble, §§p<0.01, 
§§§p<0.001 vs. shHdac3.   
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However, cytosolic acetyl-CoA for de novo lipogenesis can be generated also from 
acetate via Acetyl-CoA Synthetase, ACSS2. For these reasons, we also performed 
Acss2 and Hdac3 co-silencing in C3H/10T1/2 cells at day 0 of differentation. 
Western blot analysis confirmed Acss2 knock down upon ShAcss2 treatment 
(Figure 46). 
 
Figure 46: western blotting confirmed Acss2 silencing in C3H/10T1/2 cell line.  
 
 Contrary to what seen with Acly knock down, ShAcss2 co-silencing did not 
abrogate gene expression upregulation (Figure 47a). In fact, cell morphology of 
ShAcss2 treated cells appeared comparable to that of Scramble or ShHdac3 cells 
(Figure 47b).  
 
Figure 47: a) Expression of genes important for metabolic rewiring upon Hdac3 
ablation in Scramble, ShAcss2, ShAcss2 and ShHdac3 + ShAcss2 treated C3/H10T1/2 
cells. One way ANOVA, Tukey as post hoc test; *p<0.05, **p<0.01, ***p<0.001 vs 
Scramble, §p<0.05, §§p<0.01, §§§p<0.001 vs shHdac3, #p<0.05, ##p<0.01, vs 
shAcss2. b) Morphology of Scramble, ShHdac3, ShAcss2 and ShHdac3 + ShAcss2 treated 
C3/H10T1/2 cells. Scale bar is 50 µm.  
 
These results ruled out the effects consequent to Hdac3 ablation were dependent 
on ACSS2 activity. On the contrary, these data demonstrated that ACLY played 
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a relevant role in regulating both metabolism and epigenetic regulation of 
transcription in H3atKO mice.  
High fat diet attenuates H3atKO phenotype  
 
Hdac3 ablation induced browning of WAT, accompanied by peculiar metabolic 
rearrangement. In light of these promising results, we next asked whether Hdac3 
knock out was able to counteract obesity. To this end, we fed H3atKO and 
Floxed mice with high fat diet (HFD) for 24 weeks. Surprisingly, we observed no 
differences in body weight gain (Figure 48a), no amelioration of glucose clearance 
as measured by glucose tolerance test (GTT) (Figure 48b). Upon cold exposure, 
H3atKO mice were no longer able to maintain higher body temperature than 
Floxed mice (Figure 48c), as observed with LFD. In fact, we did not observe nor 
multilocular adipocytes in H&E histological pictures (Figure 48d) neither 
increased expression of browning markers (Figure 48e).  
 
 
Figure 48 a) Body weight gain in HFD fed Floxed and H3atKO mice. b) Glycaemia 
levels during glucose tolerance test (GTT) and related area under the curve (AUC) in 
HFD fed Floxed and H3atKO mice. c) Body temperature measurements upon exposure 
to 4°C for 100 minutes and related area under the curve (AUC) of HFD fed Floxed and 
H3atKO mice. d) IngWAT H&E in HFD fed Floxed and H3atKO mice. Scale bar is 
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100 µm. e) Expression of genes related to browning in HFD fed Floxed and H3atKO 
mice. Student’s t test.  
 
Gene expression reprogramming was absent when H3atKO were fed HFD: in 
fact, we measured expression of several genes belonging to biological patterns 
relevant for H3atKO metabolic rewiring (adipocyte functionality, oxidative 
metabolism, fatty acid β-oxidation, lipolysis, lipogenesis and glucose and citrate 
metabolism) (Figure 49 a-d) but we did not detect any differences, except for Fasn 
expression. 
 
Figure 49: analysis of expression of genes related to adipocyte functionality, oxidative 
metabolism and fatty acid β-oxidation (a), lipolysis and fatty acid β-oxidation and 
lipogenesis (b), glucose metabolism (c) and citrate metabolism (d) in HFD fed Floxed 
and H3atKO mice. Student’s t test; *p<0.05 vs Floxed mice.  
 
Therefore, this suggests that futile cycle of fatty acid was not induced at least in 
terms of gene expression when H3atKO were fed HFD.  
Metabolomic analysis (Figure 50a-b) did not highlight any specific metabolic 
pattern, thus suggesting that also at metabolite level Hdac3 ablation did not exert 
any effect during exposure to high fat diet.  
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Figure 50: heatmap (a) and volcano plot (b) of metabolites in HFD fed Floxed and 
H3atKO IngWAT.  
 
Moreover, chromatin hyperacetylation at Pparg, Ucp1 enhancers (Figure 51a) and 
Ppara putative regulatory regions (Figure 51b) was absent in HFD fed H3atKO 
mice.  
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Figure 51: ChIP-qPCR of H3K27ac at Pparg and Ucp1 enhancers (a) and Ppara 
putative regulatory regions (b) in IngWAT of HFD fed Floxed and H3atKO mice. 
Student’s t test. 
 
Unlike expected, effects of adipose Hdac3 ablation were blunted by high fat 
feeding and H3atKO displayed same obesity-like features of Floxed mice.  
Metabolic dysregulation in high fat dietary regimen overcomes the 
effects of Hdac3 knock out  
 
To understand why during HF feeding H3atKO did not display any protective 
phenotype, we considered how high fat diet might deregulate lipid metabolism in 
WAT. At this regard, it has been previously showed that HFD could reduce 
levels of lipases in adipose tissue (Shen et al. 2007). In our model, ATGL 
expression was increased in H3atKO mice both in LFD and HFD (Figure 52). 
However, increased levels of ATGL protein in H3atKO LFD fed mice were 
significantly reduced during HF feeding. 
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Figure 52: western blotting of ATGL levels in LFD and HFD fed Floxed and 
H3atKO mice. Two way ANOVA, Tukey as post hoc test; *p 0.05 vs. Floxed LFD, 
#p<0.05, ##p<0.01 vs. H3atKO LFD, §p<0.05 vs. Floxed HFD.  
 
Of note, ATGL releases FFAs that are activators of PPARs. At this regard, 
another key feature of H3atKO metabolic remodelling was the activation of 
PPARs regulatory network via increased acetylation of regulatory regions 
increasing Ppara and Pparg expression. When H3atKO mice were fed HFD, both 
Ppara (Figure 53a) and Pparg (Figure 53b) expression was decreased compared to 
that of LFD fed H3atKO mice.  
 
Figure 53: IngWAT expression of Ppara (a) and Pparg (b) in LFD and HFD fed 
Floxed and H3atKO mice. Two way ANOVA, Tukey as post hoc test; *p 0.05, 
***p<0.001 vs. Floxed LFD, ##p<0.01 vs. H3atKO LFD.  
 
These data suggested that PPARs regulatory network was no longer induced in 
HFD fed H3atKO because of lack of PPARs expression and activation. One of 
related consequences is that lypolitic program regulated by PPARα was not 
induced during HF feeding. Moreover, PPARα positively regulates expression of 
Pdk4, whose PDH inhibition is fundamental for H3atKO fatty acid futile cycle. 
As a matter of fact, Pdk4 expression is not increased in HFD fed H3atKO mice as 
result of loss of PPARα activation (Figure 54a). This was paralleled by reduced 
phosphorylation of Ser293 and Ser300 PDH in HFD fed H3atKO mice 
compared to levels of LFD fed H3atKO mice (Figure 54b-c).  
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Figure 54: a) Pdk4 expression in LFD and HFD fed Floxed and H3atKO mice. b-c) 
Western blotting analysis (b) of Ser293 and Ser300 PDH phosphorylation levels and 
related quantification (c) in IngWAT of LFD and HFD fed Floxed and H3atKO mice. 
Two way ANOVA, Tukey as post hoc test; **p<0.01, ***p<0.001 vs. Floxed LFD, 
##p<0.01, ###p<0.001 vs. H3atKO LFD.  
 
Therefore, this suggested that conversion of glucose-derived pyruvate to acetyl-
CoA was no longer blocked during HF feeding and that β-oxidation did not 
provide acetyl-CoA to feed TCA cycle and citrate synthesis. Moreover, these data 
suggested that PPARα played a relevant role in H3atKO phenotypical changes 
during LFD and that the block of its activation by HF feeding contributed to 
abrogate Hdac3 ablation effects. To further confirm these results, we treated 
Hdac3 silenced and Scramble C3/H/10T1/2 cells with PPARα inhibitor 
GW6471. As expected, GW6471 treatment attenuated Hdac3 silencing effects on 
expression of key genes Pparg, Glut4, Pdk4, Ucp1, Acadl, Acly, Fasn (Figure 55a) 
and strongly reduced number of differentiated adipocytes (Figure 55b).  
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Figure 55: a) Expression of key genes of H3atKO phenotype in Scramble or ShHdac3 
C3/H10T1/2 cells treated with vehicle or GW6471. Two-way ANOVA, Tukey as post 
hoc test; *p<0.05, ****p<0.0001 vs. Scramble + Vehicle, ###p<0.001, ####p<0.0001 vs. 
ShHdac3 + Vehicle, §p<0.05, §§p<0.01, and §§§p<0.001 vs. Scramble + GW6471.  
 b) Morphologic analysis of Scramble or ShHdac3 C3/H10T1/2 cells treated with 
vehicle or GW6471. Scale bar is 50 µm. 
 
These in vitro results further confirmed that PPARα is a pivotal actor in 
mechanisms underlying H3atKO phenotype. Furthermore, another important 
metabolic route of H3atKO phenotype is lipogenesis, whose principal regulator in 
adipose tissue is ChREBPβ. In fact, ChREBPβ expression is increased in LFD fed 
H3atKO mice (Figure 56a). However, as already demonstrated in literature, its 
expression is reduced upon HF feeding in H3atKO mice. At this regard, 
ChREBPβ expression was shown to be regulated by glucose cellular level via 
ChREBPα (Herman et al. 2012). Intracellular glucose levels in adipose tissue are 
mainly regulated by GLUT4 transporter, which is PPARγ target gene. In fact, we 
found reduced levels of Glut4 mRNA in HFD fed H3atKO mice compared to 
those of LFD fed H3atKO mice (Figure 56b), as result of reduced PPARγ 
activity.  
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Figure 56: expression of ChREBPβ (a) and Glut4 (b) in LFD and HFD fed Floxed 
and H3atKO mice. Two-way ANOVA, Tukey as post hoc test; ***p<0.001 vs. Floxed 
LFD, ##p<0.01, ####p<0.0001 vs. H3atKO LFD  
 
Therefore, these data suggested that HFD fed H3atKO displayed less adipose 
intracellular glucose levels leading to reduced ChREBPβ expression. Taken 
together, these results indicated that also lipogenic pathway was impaired when 
H3atKO mice were exposed to high fat feeding.  
Immunophenotyping revealed immune remodelling of adipose tissue 
upon Hdac3 knock out  
 
It has been demonstrated that resident immune cells play relevant roles in the 
pathophysiology of adipose tissue. For these reasons, we investigated 
immunophenotype of adipose tissue in H3atKO mice. To this end, we fed Floxed 
and H3atKO mice with LFD for 4 weeks and we performed FACS analysis on 
visceral WAT (ViscWAT) in collaboration with Prof. Catapano and Prof. Norata 
Laboratory of Lipoproteins, Immunity and Atherosclerosis, Università degli Studi 
di Milano. We chose visceral WAT because the augmentation of this adipose 
compartment is classically involved in negative effects exerted by adipose resident 
immune cells on systemic metabolism during obesity. Firstly, ViscWAT of 
H3atKO mice weighed less than that of Floxed mice, confirming our previous 
results (Figure 57a). FACS analysis showed increased number of CD45+ cells 
(Figure 57b), which represent leukocytes, in ViscWAT of H3atKO mice. Among 
leukocytes, number of dendritic cells (Cd11c+ MHCII) (Figure 57c) was not 
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different between Floxed and H3atKO mice. Interestingly, we found increased 
number of neutrophils (Ly6G+) (Figure 57d), monocytes (Ly6C+) (Figure 57e) 
and macrophages (F4/80+ MHCII) (Figure 57f).  
 
Figure 57: a) ViscWAT weight of LFD fed Floxed and H3atKO mice. b-f) Analysis of 
immune cells number in ViscWAT of LFD fed Floxed and H3atKO mice, in particular 
leukocytes (b), dendritic cells (c), neutrophils (d), monocytes (e) and macrophages (f). 
Student’s t test; *p<0.05; **p<0.01; ****p<0.0001 vs Floxed mice.  
 
We also analyzed macrophages subsets within ViscWAT and, surprisingly, we 
found 10% increase of M1 percentage (% Cd11c+/F4/80+MHCII) (Figure 58a) 
and reduction of M2 percentage (% Cd206+/F4/80+MHCII) (Figure 58b).  
 
 
Figure 58: percentage of M1 macrophages (a) and M2 macrophages (b) in ViscWAT of 
LFD fed Floxed and H3atKO mice. Student’s t test; *p<0.05 vs Floxed mice.  
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In parallel, we analyzed gene expression in epidydimal visceral WAT. qPCR 
analysis showed increased expression of M1 markers Il6 and Nos2, with no change 
in Ccl2 expression (Figure 59a-c). However, also M2 marker Ym1 expression was 
increased, accompanied by a trend of increase in Arg1 and Cx3cr1 expression, 
though not statistical significant (Figure 59d-f).  
 
 
Figure 59: expression of M1 macrophage (a, b, c) and M2 macrophage (d, e, f) markers 
in EpiWAT of LFD fed Floxed and H3atKO mice. Student’s t test; *p<0.05; 
***p<0.001 vs Floxed mice.  
 
With respect to adaptive immunity, H3atKO ViscWAT displayed increased 
number of both CD4+ (Figure 60a) and CD8+ T lymphocytes (Figure 60b). 
However, none of CD4+ and CD8+ subsets (Teffector memory TEM, Tcentral 
memory TCM, Teffector, Tnaïve) (Figure 60c-d) showed different percentage 
between Floxed and H3atKO mice. Of note, T regulatory cells (Treg, % CD25+ 
FoxP3+/CD4+) were not different between two phenotypes (Figure 60e).  
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Figure 60: analysis of adaptive immune cells number in ViscWAT of LFD fed Floxed 
and H3atKO mice, in particular CD4+ (a), CD8+ (b), CD4+ subsets (c), CD8+ subsets 
(d) and Treg (e). Student’s t test; *p<0.05; **p<0.01 vs Floxed mice.  
 
To understand whether increased number of immune cells in H3atKO ViscWAT 
resulted from increased local proliferation or increased recruitment from systemic 
circulation, we analyzed levels of immune cells in bone marrow and blood of 
Floxed and H3atKO mice. We found no differences in CD45+ leukocytes in bone 
marrow (Figure 61a). Moreover, number of circulating neutrophils (Figure 61b), 
monocytes (Figure 61c) and monocitic subsets (Ly6C high, intermediate and low) 
(Figure 61d) was not different in blood.  
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Figure 61: levels of leukocytes in bone marrow (a), neutrophils (b), monocytes (c), 
monocyte subsets (d) in blood of LFD fed Floxed and H3atKO mice. Student’s t test. 
 
Similarly, number of CD4+ T cells (Figure 62a), CD8+ T cells (Figure 62b), 
related subsets and basal Treg cells (CD4+ CD25+) showed no difference in blood 
(Figure 62c-d).  
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Figure 62: levels of CD4+ (a), CD8+ (b), CD4+ subsets (c), CD8+ subsets (d) and basal 
Treg cells in blood of LFD fed Floxed and H3atKO mice. Student’s t test. 
 
These data suggested that increased number of immune cells in adipose tissue was 
a result of increased local proliferation rather than increased recruitment. Taken 
together, these data indicated that adipocyte-specific Hdac3 ablation redefined 
population of resident immune cells within visceral adipose tissue, increasing 
presence of both innate and adaptive immune cells. Interestingly, H3atKO mice 
displayed increased percentage of M1 macrophages.  
Immunoremodeling of H3atKO ViscWAT is not altered by high fat 
diet  
 
In obesity adipose tissue resident macrophages (ATMs) participate to worsen 
systemic metabolism leading to atherosclerosis and cardiovascular disease. In 
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particular M1 macrophages have a major role in these mechanisms. In H3atKO 
mice we found increased number of macrophages with increased percentage of 
M1 subset. These results prompted us to investigate whether these effects were 
maintained or even worsen during high fat diet consumption. To this end, we fed 
Floxed and H3atKO littermates HFD for 4 weeks to detect early effects of high 
fat diet consumption. After dietary exposure we analyzed ViscWAT 
immunophenotype by FACS. After 4 weeks of HFD consumption, ViscWAT 
weight was not statistically different between two phenotypes, even though a 
trend of reduction in H3atKO mice was still present (Figure 63a). FACS analysis 
showed a striking increase in the number of CD45+ leukocytes in H3atKO 
ViscWAT, even though it was not statistical significant (p-value: 0,0579) (Figure 
63b). As measured in LFD fed mice, number of neutrophils (Ly6G+) (Figure 
63c), monocytes (Ly6C+) (Figure 63d) and macrophages (F4/80+ MHCII) (Figure 
63e) was increased in H3atKO mice, with a slight increase, not statistical 
significant, of dendritic cells (Cd11c+ MHCII) (Figure 63f).  
 
Figure 57: a) ViscWAT weight of HFD fed Floxed and H3atKO mice. b-f) Analysis of 
immune cells number in ViscWAT of HFD fed Floxed and H3atKO mice, in particular 
leukocytes (b), neutrophils (c), monocytes (d), macrophages (e),  and dendritic cells (f). 
Student’s t test; *p<0.05; **p<0.01; ***p<0.001 vs Floxed mice.  
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Among macrophages, we found no differences nor in percentage of M1 (% 
Cd11c+/F4/80+MHCII) (Figure 64a) neither M2 (% Cd206+/F4/80+MHCII) 
(Figure 64b) subsets. 
 
Figure 64: percentage of M1 macrophages (a) and M2 macrophages (b) in ViscWAT of 
HFD fed Floxed and H3atKO mice. Student’s t test.  
 
In particular, by comparing M1 percentage between two diets, we found that 
HFD consumption caused around 15% increase in % M1 subset in Floxed mice, 
whereas HFD did not change that of H3atKO mice (Figure 65). These data 
indicated that HFD consumption did not cause a further increase of M1 
macrophages in ViscWAT upon Hdac3 ablation, suggesting that Hdac3 ablation 
might exert protective effect against HFD. 
 
 FLOXED H3atKO 
LOW FAT DIET 24,24 34,01 
HIGH FAT DIET 38,32 32,53 
 
Figure 65: comparison of M1 macrophage percentage between LFD and HFD fed 
Floxed and H3atKO mice.  
 
Furthermore, qPCR analysis showed a general increased expression of M1 (Il6, 
Ccl2, Nos2) (Figure 66a-c) and M2 markers (Ym1, Arg1, Cx3cr1) (Figure 66d-f), 
with only Cx3cr1 expression reaching statistical meaning. 
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Figure 66: expression of M1 macrophage (a, b, c) and M2 macrophage (d, e, f) markers 
in EpiWAT of HFD fed Floxed and H3atKO mice. Student’s t test; ***p<0.001 vs 
Floxed mice.  
 
Similar to what found during LFD feeding, HFD fed H3atKO mice displayed 
increased levels of CD4+ (Figure 67a) and CD8+ T cells (though not statistical 
significant) (Figure 67b), with no prevalence of any T cell subset (Teffector 
memory TEM, Tcentral memory TCM, Teffector, Tnaïve) (Figure 67c-d), 
neither Treg cells (% CD25+ FoxP3+/CD4+) (Figure 67e).  
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Figure 67: analysis of adaptive immune cells number in ViscWAT of HFD fed Floxed 
and H3atKO mice, in particular CD4+ (a), CD8+ (b), CD4+ subsets (c), CD8+ subsets 
(d) and Treg (e). Student’s t test; *p<0.05 vs Floxed mice.  
 
Bone marrow and blood analysis did not show any difference in leucocytes (Figure 
68a), neutrophils (Figure 68b), monocytes (Figure 68c) and related subsets (Ly6C 
high, intermediate and low) (Figure 68d).  
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Figure 68: levels of leukocytes in bone marrow (a), neutrophils (b), monocytes (c), 
monocyte subsets (d) in blood of HFD fed Floxed and H3atKO mice. Student’s t test.  
 
Similarly, levels of CD4+, CD8+ T cells and related subsets were not changed 
upon HFD feeding (Figure 69a-d).   
 
 
Figure 69: levels of CD4+ (a), CD8+ (b), CD4+ subsets (c), CD8+ subsets (d) in blood of 
HFD fed Floxed and H3atKO mice. Student’s t test.  
 
However basal not activated Treg cells (CD4+ CD25+) levels showed a slight 
increase in H3atKO mice fed HFD (Figure 70). 
 
 
Figure 70: levels of circulating basal Treg cells in HFD fed Floxed and H3atKO mice. 
Student’s t test; *p<0,05 vs Floxed mice.   
 
Taken together, these data indicated that number of adipose immune cells in 
HFD fed H3atKO tended to increase similarly to what measured in LF feeding. 
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This suggested that ViscWAT immunoremodeling upon Hdac3 ablation was 
maintained during early phase of high fat diet exposure.  
Could HDAC3 be involved in thermogenic response to cold? 
  
Hdac3 ablation in WAT reprogrammed gene expression leading to the onset of a 
futile cycle of fatty acid β-oxidation and de novo synthesis. It has been shown that 
this peculiar metabolism is actually typical of BAT (Mottillo et al. 2014; Yu et al. 
2018). It helps, in fact, to sustain and provide energetic requirements of the 
thermogenic process. At this regard, we analysed expression of metabolic genes in 
BAT vs IngWAT of Floxed mice. BAT displayed higher expression of BAT 
markers, as expected (Figure 71). Interestingly, BAT showed strongly higher 
expression of genes belonging to glucose and citrate metabolism, like Pdk4, and 
fatty acid β-oxidation and synthesis (Figure 71), thus confirming that BAT gene 
program is characterized by higher expression of genes favouring fatty acid futile 
cycle.  
 
Figure 71: expression of genes related to BAT activity, glucose, citrate and lipid 
metabolism in IngWAT vs BAT. Student’s t test; **p<0.01; ***p<0.001 vs IngWAT.  
 
These data, together with already published evidences (Mottillo et al. 2014), led 
us to hypothesize that Hdac3 ablation in WAT unlocked transcriptional program 
similar to BAT and to that evoked by cold exposure in WAT leading to 
browning. Therefore, we exposed Floxed and H3atKO mice to 4°C for 24 hours 
to induce WAT cold response and browning and we analysed gene expression in 
IngWAT. As expected, IngWAT showed strong increased expression of Ucp1 
and Ppara when Floxed mice were exposed to 4°C vs 22°C (Figure 72). Strikingly, 
cold exposure boosted expression of Idh3a, Glut4, Pdk4, Cs, Atgl, Acadl, Acly, Fasn 
in IngWAT of Floxed mice (Figure 72). The expression of same genes was 
augmented in H3atKO mice at 22°C. Of note, H3atKO mice exposed to 4°C 
expression pattern was in most cases similar to that of H3atKO mice at 22°C.  
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Figure 72: expression of key genes for H3atKO phenotype in IngWAT of Floxed and 
H3atKO mice exposed to 4°C or at 22°C. Two way ANOVA, Tukey as post hoc test; 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 vs Floxed 22°C, #p<0.05, ##p<0.01, 
###p<0.001, ####p<0.0001 vs H3atKO 22°C, §§§p<0.001, §§§§p<0.0001 vs Floxed 
4°C.  
 
These data indicated that Hdac3 ablation induced in IngWAT the expression of 
metabolic genes similarly to cold exposure, suggesting that HDAC3 may be 
involved in WAT thermogenic response upon cold exposure. 
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Discussion 
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Adipose Hdac3 ablation induces browning of WAT, sustained by 
metabolic rewiring toward futile cycle of lipid oxidation and synthesis  
 
Adipose tissue is not merely a site of energy storage but it also plays a central role 
in the regulation of systemic metabolism (Rosen & Spiegelman 2013). Recent 
discovery of beige adipocytes paved the way for novel therapeutical approaches for 
treatment of obesity and related disorders. Our previous results showed that 
inhibition of class I HDACs ameliorated metabolic phenotype of obese murine 
models, with a peculiar role played by HDAC3 (Galmozzi et al. 2013; A. Ferrari 
et al. 2017). Based on these preliminary data we generated a mouse model lacking 
HDAC3 only in adipose tissues, by breeding Hdac3fl/fl (Floxed) x Adipoq-Cre Tg 
mice in C57BL/6J background. We found that genetic inactivation of Hdac3 in 
adipose tissues induced browning of IngWAT, paralleled by increased 
thermogenic capacity upon cold exposure. Of note, Hdac3 ablation effects were 
also observed, though to a lesser extent, in visceral epididymal WAT (EpiWAT), 
probably due to the fact that ViscWAT is less prone to undergo browning 
(Kajimura et al. 2015). In fact, subcutaneous adipocytes feature peculiar cell-
autonomous characteristics different from that of visceral depot (Rosen & 
Spiegelman 2013). Sequencing of whole transcriptome in IngWAT highlighted 
induction of gene pathways related to lipid oxidative metabolism. Of note, Hdac3 
ablation induced also gene repression, indicating that Hdac3 knock out did not 
de-repress gene expression in uncontrolled fashion but rather HDAC3 governs 
specific gene pathways of metabolic regulation. This is in line with other findings 
showing that HDAC3 is not acting only as corepressor but also as coactivator of 
transcription (Emmett et al. 2017). Browning of H3atKO mice was sustained by 
the onset of peculiar metabolic phenotype. We found that glucose utilization is re-
routed toward anaplerotic reactions feeding TCA cycle (e.g., conversion of 
pyruvate to oxaloacetate catalysed by pyruvate carboxylase). Conversely, FAs were 
preferentially oxidized to provide acetyl-CoA for citrate synthesis. FFAs are 
activators of UCP1-mediated uncoupling: on the one hand FAs directly activate 
UCP1 (Fedorenko et al. 2012), on the other hand β-oxidation produces higher 
amount of reducing equivalents (i.e., NADH and FADH2), that, in turn, supply 
electron transport chain and uncoupling. However, we observed concomitant 
activation of de novo lipogenesis. As expected from previous findings (Herman et 
al. 2012), the increased expression of ChREBPβ isoform induced the lipogenic 
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gene pathway. Therefore, in this genetically modified mouse model, we observed 
an apparently paradoxical futile cycle of FAs metabolism, whereby FA β-
oxidation and de novo FA biosynthesis pathways are active at the same time. The 
onset of lipid futile cycle is further strengthened by in vitro experiments with 
labelled palmitate, showing incorporation of labelled carbons to de novo 
synthesized palmitate. The concomitant activation of these opposite pathways 
appears to be typical of BAT metabolism upon cold or β3-adrenergic stimuli, as 
demonstrated by previous findings (Mottillo et al. 2014; Yu et al. 2018). 
Moreover, BAT or activated beige adipocytes display UCP1-independent 
thermogenic mechanisms that rely upon futile cycles of creatine (Kazak et al. 
2015) or Ca2+/ATP hydrolysis (Ikeda et al. 2018). Based on these evidences, the 
occurrence of paradoxical metabolic pathways seems to be typical of BAT 
metabolism to sustain higher energy demand of the thermogenic process. 
Therefore, Hdac3 ablation phenocopied, at least in part, BAT metabolism. These 
intriguing results prompted us to investigate molecular mechanisms underlying 
H3atKO phenotype. HDAC3 regulates transcription via epigenomic 
mechanisms. It is recruited to the genome, usually via formation of protein 
complex along with NCOR1 or NCOR2 (also known as SMRT), which are 
essential to mediate repression (Sun et al. 2013). Given that performing ChIP-
qPCR experiments on coregulators of transcription in adipose tissue presents 
notable technical limitations, we decided to measure histone acetylation as a read-
out of HDAC3 activity. Histone acetylation was not globally increased upon 
Hdac3 ablation (data not shown), as previously reported by others (Montgomery 
et al. 2008). Therefore, we focused on specific chromatin regions with a potential 
role in determining effects consequent to Hdac3 ablation. By exploiting literature 
(Ramlee et al. 2014; Abe et al. 2015) and published ChIP-Seq datasets, we found 
“hot regions” regulating Pparg, Ucp1 and Ppara genes. When we interrogated 
chromatin, we found increased H3K27ac on these regions upon Hdac3 
ablation/silencing. PPARγ plays pivotal role in the regulation of adipogenesis and 
adipocyte function. In addition, ATGL and LPL are PPARγ target genes, 
therefore PPARγ activation might also be important to induce lipolysis and FA 
uptake upon Hdac3 ablation. On the other hand, activation of PPARα gene 
network enhances FA β-oxidation. Moreover, PPARα positively regulates Pdk4 
expression, thus, in the context of H3atKO phenotype, PPARα activation also 
allowed to reroute glucose-derived pyruvate from production of acetyl-CoA to 
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anaplerotic synthesis of oxaloacetate. As a matter of fact, in vitro experiments with 
PPARα antagonist further demonstrated that this nuclear receptor contributed to 
establish metabolic rewiring upon Hdac3 genetic inactivation. Thus, Hdac3 
ablation induced metabolic rewiring and browning by epigenetic regulation of key 
genes Pparg, Ucp1 and Ppara. Histone acetylation in H3atKO mice was sustained 
by ACLY nuclear localization, as demonstrated by knockdown experiments 
showing that Acly silencing prevented hyperacetylation of chromatin regions. To 
summarize, Hdac3 ablation-driven epigenetic changes in “hot chromatin regions” 
upregulated the expression of key genes Pparg, Ucp1 and Ppara, thus inducing 
metabolic rewiring, which sustained browning of IngWAT. 
 
Figure 73: metabolic switch of H3atKO mice sustains thermogenesis (Alessandra 
Ferrari et al. 2017). 
 
Transcription factors evoked by Hdac3 ablation and activation of related 
regulatory networks is still a point that remains to be further investigated. While 
PPARγ and PPARα seem to emerge as pivotal actors in triggering molecular 
changes that determined metabolic rewiring and browning of IngWAT in 
H3atKO mice, the integration of different “omics” approaches would help to 
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further disentangle this issue. A possible approach would be to carry out ChIP-
Seq experiments analysing H3K27ac and H3K4me3 enrichment peaks that would 
detect, respectively, enhancer and promoter regions involved in transcriptional 
reprogramming underlying effects consequent to Hdac3 ablation. On the other 
hand, HDAC3 ChIP-Seq in IngWAT would identify genomic regions 
physiologically occupied by HDAC3. ATAC-Seq (Assay for Transposase-
Accessible Chromatin followed by Sequencing) experiments in H3atKO 
IngWAT would highlight DNA fragments with greater chromatin openness 
which leads to binding of transcription factors and coregulators. Possibly, the use 
of bioinformatic tools, by integrating the results of these experiments, would help 
to identify the enrichment of specific transcription factors motifs upon Hdac3 
ablation and, consequently, infer candidate transcription factors involved in 
determining transcriptional and metabolic reprogramming upon Hdac3 ablation. 
One example of these tools is HOMER (Hypergeometric Optimization of Motif 
EnRichment, available online at http://homer.ucsd.edu/homer/index.html), 
which contains several tools for de novo motif analysis in ChIP-Seq, ATAC-Seq 
and other “omics” experiments. The identification of these transcription factors 
may help to identify new possible targets that, once activated, trigger mechanisms, 
e.g. browning, that counteract obesity.  
It is important to mention that our findings do not overlap the results reported by 
Emmett et al. (Emmett et al. 2017), which showed that pan-adipose and BAT-
specific Hdac3 knock out mice were not able to cope cold exposure. These 
discrepancies could be related to different Hdac3fl/fl strains used; however, the 
authors focused their attention on BAT-specific Hdac3 knock out, showing that 
HDAC3 primed brown adipocytes to immediate thermogenic response, by 
allowing a basal tone of thermogenic gene expression. Their conclusion is not 
completely in contrast with our results, considering that in our model we did not 
detect any significant effect of Hdac3 ablation in BAT (data not shown). 
However, recent findings support our conclusion on HDAC3 role in WAT (Liao 
et al. 2018). These authors found that pharmacologic HDAC3 inhibition 
increased expression of thermogenic genes both in BAT and inguinal SubWAT 
primary cells, regardless of mouse strain, and immortalized cell lines. Importantly, 
these authors reported the same observation also in human derived adipocytes. 
Moreover, PRDM16, a critical factor for BAT and beige development, was 
involved in mediating the effects of HDAC3 inhibition. These data support our 
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hypothesis of HDAC3 as a brake of metabolic program driving thermogenesis in 
IngWAT.  
High fat diet blunts the effects of Hdac3 ablation  
 
The induction of browning and/or BAT activation confers protection against 
obesity and related disorders. The exciting phenotype observed in H3atKO mice 
prompted us to investigate whether Hdac3 ablation exerted protective properties 
against obesity and related systemic metabolic dysfunction. However, when we 
exposed H3atKO mice to HFD for 24 weeks, we detected no difference in 
H3atKO mice compared to Floxed mice. To explain why HFD offset H3atKO 
phenotype, we focused on lipid metabolism regulation by HFD itself. Notably, it 
has been shown that HFD reduces levels of ATGL in adipose tissue (Shen et al. 
2007). Therefore, the tissue is releasing less FFAs, which are known activators of 
PPARs. The expression of PPARs was not augmented in H3atKO mice fed 
HFD, which correlated with lack of increased acetylation of histone at chromatin 
regions regulating Ppara and Pparg genes. It is conceivable that PPARs were also 
less active, due to less availability of FFAs as ligands of these two nuclear 
receptors. Consequently, activation of PPARα- and PPARγ-regulated gene 
networks were blunted upon HFD feeding. As such, PDK4-mediated shift of 
glucose metabolism is overridden by HFD, because Pdk4 is a known target gene 
of PPARα. Moreover, UCP1 was less active as well, due to the lack of FFAs. 
Therefore, HFD impaired UCP1 activation and PPARα-mediated regulation of 
lipolysis and fatty acid β-oxidation. In addition, ChREBPβ expression was also 
reduced in mice on HFD and, as a consequence, its target lipogenic genes. 
Therefore, in accordance with previous findings (Herman et al. 2012), de novo 
lipogenesis was diminished upon HF feeding. Overall, these evidences imply that 
HFD modulated by itself lipid metabolism, thus, by interfering with epigenomic 
regulation mediated by Hdac3 ablation, HFD overcame H3atKO metabolic 
phenotype.  
Immunophenotype of H3atKO ViscWAT reveals HDAC3 as a new 
possible regulator of immune function of adipose tissue  
 
Innate and adaptive immune cells resident in adipose tissue play important role in 
the regulation of adipocytes function and systemic metabolism (Mathis 2013). 
Immune cells are not only involved in aetiology of obesity-related metabolic 
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disturbances but they also modulate physiological functions such as 
thermogenesis, adipose tissue angiogenesis and remodelling (Choe et al. 2016). 
The recent attention on immune partners in the pathophysiology of adipose tissue 
prompted us to analyse immunophenotype of H3atKO ViscWAT. Unexpectedly, 
we observed that Hdac3 ablation in adipocytes also influenced the presence of 
immune cells in adipose tissue, with respect to both the innate and adaptive 
components of the immune system. In fact, we detected increased number of 
monocytes, neutrophils and macrophages and CD4+ and CD8+ T lymphocytes, 
with no increased prevalence of any T cell subsets. When considering 
macrophages, we noticed increased percentage of M1 over M2 macrophages, but 
gene expression of macrophage markers showed increase in both M1 and M2 
markers upon Hdac3 ablation. Of note, analysis of blood and bone marrow 
suggested that higher number of immune cells in H3atKO ViscWAT was caused 
by increased local proliferation rather than recruitment from systemic circulation. 
Adipocytes death induces recruitment of macrophages, in particular apoptotic-like 
cell death appeared to induce M2 macrophages recruitment (Fischer-posovszky et 
al. 2018). However, the recent study of Hill et al. (Hill et al. 2018) has 
revolutionized the classical M1/M2 paradigm, by the identification of different 
classes of macrophages (CD9+ and Ly6C+) that do not display predominant 
characteristics of M1 or M2 activation, as assessed by transcriptome analysis. At 
this regard, it has been recently demonstrated that M1 and M2 are both involved 
in tissue repairing processes after adipocyte death (Choe et al. 2016). In particular, 
Kato et al. (Kato et al. 2014) observed the presence of both M1 and M2 
macrophages after fat grafting. The authors proposed the hypothesis whereby M1 
macrophages are involved in phagocytosis of dead adipocytes, particularly in the 
regenerating zone, where adipogenesis supplies the tissue with newly 
differentiated adipocytes without fibrotic area. At the same time both M1 and M2 
macrophages are involved in hypoxic and necrotic area where M1 absorption of 
extra lipids from necrotic cells is subsequently followed by M2-induced 
fibrogenesis. This study suggested possible unrecognized roles of M1 
macrophages that are not necessarily detrimental for metabolic function. To 
explain the upsurge of macrophages in our H3atKO mouse, particularly M1, we 
are tempted to speculate that mechanisms of cell death and adipogenesis-driven 
cell renewal are activated upon Hdac3 ablation. Possibly, increased metabolic rate 
induces cell death and macrophages are involved in removal of dead cells. 
However, the possible occurrence of these mechanisms remains to be further 
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investigated to test this hypothesis. Moreover, analysis of immunophenotype 
revealed that early HFD exposure did not substantially change the tendency of 
H3atKO ViscWAT to be enriched of immune cells. This indicates that Hdac3 
adipose-specific knock out caused rewiring of ViscWAT immunophenotype, 
which is maintained in the early phases of HFD exposure. Interestingly, HFD 
feeding did not increase the number of M1 macrophages in H3atKO mice, as 
opposed to Floxed control mice and in agreement with published literature. It 
would be of great interest to investigate whether genetic inactivation or 
pharmacological inhibition of HDAC3 in adipose tissue would confer protection 
against inflammation-related impairments in systemic metabolism and insulin 
sensitivity. 
HDAC3 is emerging as a new possible regulator of thermogenic 
response to cold 
 
Hdac3 ablation in adipose tissue rewired metabolism toward a futile cycle of fatty 
acid oxidation and synthesis that sustained thermogenesis and browning. 
Therefore, we propose HDAC3 as molecular brake of thermogenesis-supporting 
metabolism in WAT. By comparing gene expression in IngWAT between Floxed 
mice exposed at 4°C and H3atKO at room temperature, we noticed that Hdac3 
ablation induced similar gene expression pattern to that induced by cold in Floxed 
mice. These data were confirmed also in in vitro experiments showing that Hdac3 
silencing, phenocopied, at least in part, the effects consequent to β-adrenergic 
stimulation with isoproterenol in terms of gene expression and isotope labelled 
metabolites (data not shown). Interestingly, Liao et al. (Liao et al. 2018) recently 
showed that HDAC3 protein levels were markedly reduced upon chronic cold 
exposure both in BAT and inguinal SubWAT. Of note, Hdac3 mRNA did not 
parallel the same pattern: in fact BAT Hdac3 mRNA were slightly higher in BAT 
versus SubWAT at room temperature, as also observed by us (data not shown). 
However, BAT showed less amount of HDAC3 protein than SubWAT in mice 
kept at room temperature. In parallel, Hdac3 mRNA showed mild increase only in 
SubWAT upon cold.  Notably, another recent paper further strengthens the 
hypothesis that HDAC3 is involved in cold response. Yuliana et al. (Yuliana et al. 
2018) reported that β-adrenergic stimulation by isoproterenol treatment increased 
H3K27ac at Ucp1 enhancer and proximal regions in primary inguinal 
subcutaneous adipocytes. The authors also found that HDAC activity was 
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reduced upon isoproterenol treatment and that Hdac3 and Hdac8 expression 
inversely correlated with Ucp1 expression. In addition, the authors found reduced 
HDAC3 recruitment at Ucp1 enhancer and proximal regions after isoproterenol 
treatment. Finally, silencing in vitro experiments suggested that HDAC3 
regulation of Ucp1 expression relied on β-adrenergic stimulation, even though this 
result was not totally confirmed by pharmacological inhibition experiments.  
Thus, our results, together with findings of other laboratories, strongly suggest 
HDAC3 as one of the actors involved in the regulation of thermogenic response 
to cold in WAT.  
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Conclusions 
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The evidences reported in this thesis demonstrated that HDAC3 is a molecular 
brake of metabolic program that supports thermogenesis and browning of white 
adipose tissue (WAT). By exploiting a mouse model with adipose-specific 
ablation of Hdac3, we discovered that Hdac3 inactivation induced rearrangements 
of specific chromatin regions regulating the key genes Pparg, Ppara and Ucp1. In 
turn, this drove gene reprogramming that sustained a metabolic shift towards a 
futile cycle of fatty acid β-oxidation and de novo lipogenesis. According to this 
model, the futile cycle of fatty acid metabolism supports browning of WAT and 
increases the thermogenic capacity of WAT. However, Hdac3 ablation was not 
able to prevent the metabolic impairments consequent to high fat diet exposure. 
This was due to impaired regulation of lipid metabolism by high fat diet exposure, 
which offset the phenotype induced by genetic inactivation of Hdac3. Adipose-
specific Hdac3 ablation also remodelled immunophenotype of visceral WAT, 
which was characterized by higher number of innate and adaptive immune cells 
both in low fat and in high fat diet. The role of immunoremodeling of ViscWAT 
on systemic metabolism and insulin sensitivity in H3atKO mice will be further 
elucidated in future experiments. Based on our results and on published literature 
by other investigators, we propose HDAC3 as a crucial regulator of adipose tissue 
metabolism and phenotype.  
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